nifedipine has been researched along with Cardiovascular Stroke in 335 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The rationale for the use of nifedipine in patients with acute myocardial infarction (MI) is based on the various cardiovascular actions of the compound: reduction of myocardial oxygen consumption by attenuation of cardiac and vascular smooth muscle tension; augmentation of oxygen and substrate supply after increased coronary blood flow with dilatation of epicardial coronary arteries (particularly in coronary obstructions) and dilatation of coronary resistance and collateral vessels; myocardial 'protection', i." | 10.16 | Myocardial infarction. Secondary prevention with nifedipine. ( Ebner, F; Rafflenbeul, W, 1991) |
| "Preliminary experimental and clinical data suggest that nifedipine can abort early acute myocardial infarction (AMI) or decrease infarct size by reversal of coronary artery spasm, improved coronary flow to the ischemic zone, reduction in myocardial oxygen demand or protection of ischemic cells." | 10.15 | Nifedipine in acute myocardial infarction. ( Pearle, DL, 1984) |
| "These results indicate that nifedipine more effectively prevented admission for angina pectoris by inhibiting the progression of coronary artery disease in patients with a history of MI." | 9.12 | Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy). ( Haze, K; Hirayama, A; Hosoda, S; Kawai, C; Kodama, K; Nonogi, H; Shinoda, E; Sumiyoshi, T; Yui, Y, 2007) |
| "A total of 1054 postmyocardial infarction patients were divided randomly into those being treated with calcium antagonists (n = 566 [nifedipine, 425 patients and diltiazem, 141 patients]) and controls (no calcium antagonist; n = 488)." | 9.09 | Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group. ( Ishikawa, K; Kanamasa, K; Kimura, A; Miyataka, M; Takenaka, T, 1999) |
| "This study showed that use of short-acting nifedipine and diltiazem in this postmyocardial infarction population was associated with a 24% higher cardiac event rate, but this strong adverse trend did not reach statistical significance." | 9.08 | Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. ( Hama, J; Ishikawa, K; Kanamasa, K; Katori, R; Kimura, A; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yabushita, H; Yamamoto, K; Yamamoto, T, 1997) |
| "This study was intended to determine the 5-year mortality of 2138 post-myocardial infarction (MI) patients who took part in the Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT)." | 9.08 | Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. ( Behar, S; Boyko, V; Goldbourt, U; Kaplinsky, E; Mandelzweig, L; Reicher-Reiss, H, 1998) |
| " The purpose of this study was to assess the risk ratio for cancer mortality associated with nifedipine in a large population of patients post-myocardial infarction." | 9.08 | Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction. ( Behar, S; Boyko, V; Goldbourt, U; Jonas, M; Mandelzweig, L; Reicher-Reiss, H, 1998) |
| "The administration of nifedipine, 30 mg/d, between 7 and 22 days after hospitalization for an acute myocardial infarction (Secondary Prevention Reinfarction Israel Nifedipine Trial study) showed no effect on subsequent mortality and morbidity." | 9.07 | Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. ( Behar, S; Goldbourt, U; Kaplinsky, E; Mandelzweig, L; Reicher-Reiss, H; Zion, M, 1993) |
| "To ascertain whether predischarge arteriography is beneficial in patients with acute myocardial infarction treated with recombinant tissue-type plasminogen activator (rt-PA), heparin and aspirin, the outcome of 197 patients in the Thrombolysis in Myocardial Infarction (TIMI) IIA study assigned to conservative management and routine predischarge coronary arteriography (routine catheterization group) was compared with the outcome of 1,461 patients from the TIMI IIB study assigned to conservative management without routine coronary arteriography unless ischemia recurred spontaneously or on predischarge exercise testing (selective catheterization group)." | 9.07 | Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators. ( Babb, JD; Baim, DS; Braunwald, E; Chesebro, JH; Frederick, M; Gore, JM; Passamani, ER; Roberts, R; Rogers, WJ; Williams, DO, 1991) |
| "14 CCUs in Israel participated in a double-blind, placebo controlled, randomized trial of nifedipine, 30 mg/day, for the secondary prevention of myocardial infarction (MI)." | 9.06 | [Nifedipine in secondary prevention after myocardial infarction. SPRINT Study Group]. ( , 1989) |
| "The efficacy of nifedipine in the prevention of post-infarction morbidity and mortality was evaluated in a double-blind clinical trial of 2276 survivors of acute myocardial infarction recruited from the cardiac departments of 14 Israeli hospitals." | 9.06 | Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group. ( , 1988) |
| "The haemodynamic impact of alpha- and beta-adrenoceptor blockade (labetalol) was compared with that of slow-calcium channel blockade (nifedipine) in 32 patients with sustained elevation of systemic arterial pressure (systolic blood pressure greater than 160; diastolic blood pressure greater than 95 mmHg) following a recent myocardial infarction (6-22 h)." | 9.06 | Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine. ( Hussain, M; Nelson, GI; Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP; Wilson, JA, 1988) |
| "In a double-blind placebo-controlled trial to study the effect of nifedipine on ventricular arrhythmias among patients with acute myocardial infarction, 434 patients with suspected myocardial infarction were randomized within 6 h from the onset of chest pain to treatment with nifedipine (p = 217) or placebo (p = 217)." | 9.06 | Effect of nifedipine on arrhythmias in the acute phase of myocardial infarction. ( Adgey, AA; MacKenzie, G; Walker, LJ, 1988) |
| "Over 30 months 9292 consecutive patients admitted to nine coronary care units with suspected myocardial infarction were considered for admission to a randomised double blind study comparing the effect on mortality of nifedipine 10 mg four times a day with that of placebo." | 9.06 | Trial of early nifedipine in acute myocardial infarction: the Trent study. ( Banks, DC; Birkhead, JS; Brooksby, IA; Burns-Cox, CJ; Hampton, JR; Hayes, MJ; Joy, MD; Malcolm, AD; Mather, HG; Wilcox, RG, 1986) |
| "In a double blind placebo controlled trial, 434 patients with suspected myocardial infarction were randomised to treatment with nifedipine (n = 217) or placebo (n = 217) within six hours from the onset of chest pain." | 9.06 | Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction. ( Adgey, AA; MacKenzie, G; Walker, LJ, 1988) |
| "The influence of nifedipine on left ventricular ejection fraction, infarct size, and infarct expansion was studied in a prospective, double blind, randomised, placebo controlled trial in 132 patients with low risk acute myocardial infarction of less than 12 hours duration, defined by an initial left ventricular ejection fraction greater than 35% and clinical Killip class of less than or equal to II." | 9.06 | Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trial. ( Becker, LC; Chandra, NC; Flaherty, JT; Gottlieb, SH; Gottlieb, SO; Mellits, ED; Ouyang, P; Shapiro, EP; Townsend, SN; Weiss, JL, 1988) |
| "SPRINT was a double-blind, randomized placebo controlled multi-centre trial based in Israel, designed to test whether nifedipine 10 mg X 3 daily would reduce morbidity and mortality during 1 year follow-up in 2279 male and female survivors of acute myocardial infarction." | 9.06 | Calcium antagonists in secondary prevention after acute myocardial infarction: the Secondary Prevention Reinfarction Nifedipine Trial (SPRINT). ( Neufeld, HN, 1986) |
| "In this single centre prospective, double blind study, 98 patients with suspected acute myocardial infarction (AMI) were randomized, within six hours, to nifedipine 10 mg (46 patients) or placebo (52 patients) both administered sublingually." | 9.06 | Effect of early treatment with nifedipine in suspected acute myocardial infarction. ( Branagan, JP; Collins, WC; Kelly, P; McCafferty, D; Walsh, K; Walsh, MJ, 1986) |
| "Twenty-six patients with acute myocardial infarction (mean delay time 6 hours after onset of symptoms) were randomized to control or nifedipine treatment (10 mg sublingually, followed by 10 mg every 6 hours for a total of 24 hours)." | 9.05 | Hemodynamic effects of sublingual nifedipine in acute myocardial infarction. ( Eichler, HG; Gordon, GD; Isaacs, S; Lloyd, EA; Mabin, TA; Opie, LH, 1984) |
| "Preliminary clinical and laboratory observations suggest that nifedipine might prevent progression of threatened myocardial infarction by reversing coronary spasm or might limit necrosis during the course of acute myocardial infarction." | 9.05 | Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. ( Morrison, J; Muller, JE; Pearle, DL; Roberts, R; Rosner, B; Rude, RE; Schneider, JF; Serfas, DH; Stone, PH; Turi, ZG, 1984) |
| "In a double-blind trial, 30 patients with suspected acute myocardial infarction with onset of symptoms within the previous 24 h were randomized to treatment with 10 mg nifedipine/placebo orally 4 times a day during hospitalization." | 9.05 | Hemodynamic and clinical findings after combined therapy with metoprolol and nifedipine in acute myocardial infarction. ( Emanuelsson, H; Herlitz, J; Hjalmarson, A; Holmberg, S; Waagstein, F; Waldenström, A; Waldenström, J, 1984) |
| "In a multicenter double-blind study, 227 patients with suspected acute myocardial infarction (AMI) were randomized within 12 hr from onset of symptoms to treatment with nifedipine (112 patients) or placebo (115 patients)." | 9.05 | Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial. ( Bathen, J; Drivenes, A; Frøland, GS; Kjekshus, JK; Landmark, K; Overskeid, K; Pedersen, TR; Rokseth, R; Sirnes, KE; Sirnes, PA, 1984) |
| "To evaluate the hemodynamic effects of nifedipine on anginal patients during exercise in the upright position, a placebo (P) and 20 mg of nifedipine were administered in a double-blind random sequence to ten patients presenting with exertional angina and a healed myocardial infarction." | 9.05 | Acute effects of chewable nifedipine on hemodynamic responses to upright exercise in patients with prior myocardial infarction and effort angina. ( Angelino, PF; Baduini, G; Marra, S; Paolillo, V; Spadaccini, F, 1983) |
| "Fifty-seven consecutive patients with acute myocardial infarction (AMI), admitted to a coronary care unit (CCU) within 6 h from onset of symptoms were included in the study and randomly allocated to nifedipine treatment or placebo." | 9.05 | Complexity of enzyme release during acute myocardial infarction in a controlled study with early nifedipine treatment. ( Groth, T; Loogna, E; Mogensen, L; Sylvén, C, 1985) |
| "Nifedipine administration for hypertensive emergencies can induce neurological and cardiac events due to abrupt hypotension." | 8.80 | Hypotension and coronary events on nifedipine: reassessing nifedipine safety. ( , 1998) |
| "A 34-year-old mother developed acute myocardial infarction (MI) 10 days postpartum while taking bromocriptine for ablactation." | 7.69 | Acute myocardial infarction in a healthy mother using bromocriptine for milk suppression. ( Hopp, L; Iffy, L; Weisse, AB, 1996) |
| "The effect of nifedipine on ventriculoarterial coupling was examined in 8 patients with old myocardial infarction who showed a depressed ejection fraction (37 +/- 7%)." | 7.69 | The effect of nifedipine on ventriculoarterial coupling in old myocardial infarction. ( Fujii, T; Hiro, T; Katayama, K; Kohno, M; Matsuzaki, M; Miura, T; Seki, K; Yano, M, 1996) |
| "The impact of intravenous infusion of nifedipine and nitroglycerin on invasive central hemodynamic parameters and microcirculation was compared in 94 patients with acute myocardial infarction complicated by heart failure." | 7.68 | [Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin]. ( Gruzdev, AK; Kosminskiĭ, PG; Lazarev, IA; Magnitskiĭ, AV; Sidorenko, BA; Vaniev, SB; Vasechkin, SS, 1992) |
| "The efficacy of intravenous nifedipine was examined in 42 patients with acute myocardial infarction complicated by congestive heart failure." | 7.68 | [Use of intravenous nifedipine in the treatment of cardiac insufficiency in the acute period of myocardial infarction]. ( Gruzdev, AK; Kosminskiĭ, PG; Magnitskiĭ, AV; Sidorenko, BA; Vaniev, SB; Vasechkin, SS, 1991) |
| "The acute effect of nifedipine (Adalat, Bayer) was evaluated in 54 men with a history of transmural myocardial infarction." | 7.67 | Evaluation of the effect of nifedipine in men after myocardial infarction. ( Jedlicka, J; Kidéry, J; Málek, I; Nestával, A; Oppelt, A; Stanĕk, V, 1984) |
| "The haemodynamic dose-response effects of the slow-calcium channel blocker nicardipine were evaluated in fifteen male patients with uncomplicated acute myocardial infarction." | 7.67 | Haemodynamic effects of nicardipine in acute myocardial infarction. ( Frais, MA; Hafizullah, M; Jackson, NC; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "We observed marked gingival hyperplasia, similar clinically and histologically to the hyperplasia caused by 5:5 sodium diphenylhydantoin (Dilantin) during the last 18 months in five patients treated by nifedipine." | 7.67 | Gingival hyperplasia caused by nifedipine--a preliminary report. ( Behar, S; Engelberg, IS; Kishon, Y; Ramon, Y, 1984) |
| "The use of nifedipine in patients with hypertension, heart failure, and acute myocardial infarction is discussed." | 7.67 | Nifedipine in hypertension and heart failure. ( Matsui, S; Murakami, E; Murakami, H; Takekoshi, N, 1984) |
| "The haemodynamic effects of nifedipine (20 mg sublingually) were studied in 40 patients with acute myocardial infarction within 18 h of the onset of symptoms." | 7.67 | Nifedipine following acute myocardial infarction--dependence of response on baseline haemodynamic status. ( Jackson, NC; Nelson, GI; Reynolds, GW; Silke, B; Taylor, SH; Verma, SP; Wilson, JA, 1987) |
| "The effects of the two calcium antagonists bepridil and nifedipine on induced ventricular tachyarrhythmias were studied by programmed electrical stimulation in 15 dogs, 4-8 days after myocardial infarction." | 7.67 | Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs. ( Aidonidis, I; Brachmann, J; Dembowsky, K; Kuebler, W; Seller, H, 1989) |
| "m-Nisoldipine iv 3, 5 and 10 micrograms/kg before coronary artery ligation markedly reduced the early ischemic arrhythmia in conscious rats." | 7.67 | [Effects of m-nisoldipine on ischemic arrhythmia in conscious rats]. ( An, RH; Fu, SX; Li, YS, 1989) |
| "The comparative effects of the calcium-antagonists gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, particularly ventricular fibrillation (VF), were assessed in a total of 40 mongrel dogs in two experimental preparations." | 7.67 | Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds. ( Bender, F; Gülker, H; Haverkamp, W; Hindricks, G, 1987) |
| "Twelve male patients age 36-66, 8 on clinical doses of beta blocker, with old transmural myocardial infarction underwent rest and matched workload exercise before and 30 min after 20 mg sublingual nifedipine during cardiac catheterization." | 7.67 | Acute hemodynamic effects of nifedipine during supine exercise in patients with prior myocardial infarction. ( Cha, SD; MacMillan, RM; Maranhao, V, 1986) |
| "To examine whether nicardipine, a dihydropyridine derivative, limits size of myocardial infarction, and to compare the protective effects of nicardipine administered before and early and late after coronary artery occlusion, 99mTc-labeled albumin microspheres were injected into the left atrium during 5 min temporary coronary artery occlusion to determine the extent of the hypoperfused zone (the area at risk)." | 7.67 | Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. ( Endo, T; Fujita, S; Hayakawa, H; Iida, N; Kikuchi, K; Kiuchi, K; Nejima, J; Okumura, H, 1986) |
| "In conclusion, we observed first that nifedipine is highly efficacious in preventing the coronary vasospasm of Prinzmetal's variant angina." | 7.66 | Nifedipine therapy for coronary vasospasm. ( Antman, EM; Muller, JE; Stone, PH, 1983) |
| "Nitroglycerin ointment and nifedipine were used concurrently for vasodilator therapy in 10 patients with acute myocardial infarction." | 7.66 | Hemodynamic effects of concomitant nitroglycerin ointment and nifedipine treatment in acute myocardial infarction. ( Kanaya, H; Mori, K; Ohka, T; Onoe, T, 1982) |
| "The efficacy of nifedipine in relieving recurrent ischemic episodes following acute myocardial infarction was studied in 11 patients a mean of 9." | 7.66 | Nifedipine therapy for recurrent ischemic pain following myocardial infarction. ( Muller, JE; Stone, PH, 1982) |
| "In consideration of the results of experimental studies indicating that nifedipine, a vasodilating calcium antagonist with little inotropic or electrophysiological effects, increases coronary flow to both normal and ischemic zones potentially rendering protection of ischemic myocardium as well as the results of clinical studies in patients with angina pectoris, this pilot study was carried out in patients with acute myocardial infarction to evaluate the clinical, hemodynamic and electrophysiological responses." | 7.66 | Nifedipine and acute myocardial infarction. ( Henry, PD; Jaffe, AS; Roberts, R; Sobel, BE, 1981) |
| "The acute haemodynamic effects of nifedipine (10 mg sublingually) and isosorbide dinitrate (5 mg sublingually) were compared in 13 patients with heart failure due to acute myocardial infarction." | 7.66 | Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction. ( Bracchetti, D; Cantelli, I; Naccarella, F; Pavesi, PC, 1981) |
| "10 patients recovering from acute myocardial infarction with stable symptomatology, underwent 3 subsequent ergometric trials: the first, basic, the second, after one month of practice on an ergometer bicycle and the third, with a longer period of training, after acute administration of nifedipine." | 7.66 | [The effects of physical training and nifedipine on patients recovering from acute myocardial infarction (author's transl)]. ( De Rosa, L; Greco, V; Latini, S; Matteoli, S; Trappolini, M; Volpe, N, 1981) |
| "The hemodynamic effects of a single oral dose of 20 mg of nifedipine were studied in 21 stable patients after an acute myocardial infarction before withdrawal of Swan-Ganz and intra-arterial catheters." | 7.66 | Hemodynamic effects of a single oral dose of nifedipine following acute myocardial infarction. ( Debaisieux, JC; Mizgala, HF; Theroux, P; Waters, DD, 1980) |
| "Nineteen patients in the acute stage of transmural myocardial infarction were given 20 mg nifedipine orally under haemodynamic control." | 7.66 | [Nifedipine in acute myocardial infarction (author's transl)]. ( Beck, OA; Halilović, E; Hochrein, H; Oeff, M, 1980) |
| "The rationale for the use of nifedipine in patients with acute myocardial infarction (MI) is based on the various cardiovascular actions of the compound: reduction of myocardial oxygen consumption by attenuation of cardiac and vascular smooth muscle tension; augmentation of oxygen and substrate supply after increased coronary blood flow with dilatation of epicardial coronary arteries (particularly in coronary obstructions) and dilatation of coronary resistance and collateral vessels; myocardial 'protection', i." | 6.16 | Myocardial infarction. Secondary prevention with nifedipine. ( Ebner, F; Rafflenbeul, W, 1991) |
| "Nine randomized trials in patients with acute myocardial infarction have been performed to assess the effect of nifedipine on infarct size, reinfarction and/or survival." | 6.16 | Review of calcium antagonist trials in acute myocardial infarction. ( Roberts, R, 1989) |
| "Preliminary experimental and clinical data suggest that nifedipine can abort early acute myocardial infarction (AMI) or decrease infarct size by reversal of coronary artery spasm, improved coronary flow to the ischemic zone, reduction in myocardial oxygen demand or protection of ischemic cells." | 6.15 | Nifedipine in acute myocardial infarction. ( Pearle, DL, 1984) |
| "Patients with unstable angina pectoris who remain symptomatic at rest after hospitalization are at increased risk of death or myocardial infarction." | 5.27 | Adjunctive nifedipine therapy in high-risk, medically refractory, unstable angina pectoris. ( Blaustein, AS; Heller, GV; Kolman, BS, 1983) |
| "Nifedipine was infused intravenously for 5 hr beginning 15 min (n = 9) and 3 hr (n = 6) after permanent occlusion of the midcircumflex coronary artery and compared with early and delayed vehicle treatment (controls; n = 9)." | 5.27 | Protective effect of early and late treatment with nifedipine during myocardial infarction in the conscious dog. ( Becker, LC; Hutchins, GM; Melin, JA, 1984) |
| "Nifedipine is an effective agent for the treatment of postinfarction heart failure accompanied with high peripheral resistance." | 5.27 | [Use of nifedipine for treating heart failure in the subacute period of myocardial infarct in patients over 60]. ( Chistova, VS; Glezer, MG; Iakovlev, SV; Lazutin, VK; Sergeeva, EV, 1987) |
| " The equi-effective dosage was 0." | 5.27 | Comparison of the acute hemodynamic response to intravenous nisoldipine (Bay k 5552) and intravenous nifedipine for left ventricular dysfunction secondary to myocardial infarction. ( Aschenberg, W; Bleifeld, W; Clausen, A; Fehr, A; Nienaber, CA; Spielmann, RP, 1987) |
| "Nifedipine was discontinued in 3 patients because of hypotension (SBP less than 90), rapid atrial fibrillation, and complete heart block in one patient each." | 5.27 | Nifedipine infusion in acute myocardial infarction: experience in twelve patients. ( Barnett, DB; Bing, RF; Heagerty, AM; Pohl, JE; Walley, TJ; Woods, KL, 1987) |
| " Nicardipine given by three different dosing schedules to baboons markedly limited myocardial infarction over a 6 h period of LAD occlusion." | 5.27 | Nicardipine in models of myocardial infarction. ( Alps, BJ; Calder, C; Wilson, A, 1985) |
| "These results indicate that nifedipine more effectively prevented admission for angina pectoris by inhibiting the progression of coronary artery disease in patients with a history of MI." | 5.12 | Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy). ( Haze, K; Hirayama, A; Hosoda, S; Kawai, C; Kodama, K; Nonogi, H; Shinoda, E; Sumiyoshi, T; Yui, Y, 2007) |
| "A total of 1054 postmyocardial infarction patients were divided randomly into those being treated with calcium antagonists (n = 566 [nifedipine, 425 patients and diltiazem, 141 patients]) and controls (no calcium antagonist; n = 488)." | 5.09 | Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group. ( Ishikawa, K; Kanamasa, K; Kimura, A; Miyataka, M; Takenaka, T, 1999) |
| "This study showed that use of short-acting nifedipine and diltiazem in this postmyocardial infarction population was associated with a 24% higher cardiac event rate, but this strong adverse trend did not reach statistical significance." | 5.08 | Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group. ( Hama, J; Ishikawa, K; Kanamasa, K; Katori, R; Kimura, A; Nakai, S; Ogawa, I; Oyaizu, M; Takenaka, T; Yabushita, H; Yamamoto, K; Yamamoto, T, 1997) |
| "This study was intended to determine the 5-year mortality of 2138 post-myocardial infarction (MI) patients who took part in the Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT)." | 5.08 | Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. ( Behar, S; Boyko, V; Goldbourt, U; Kaplinsky, E; Mandelzweig, L; Reicher-Reiss, H, 1998) |
| " The purpose of this study was to assess the risk ratio for cancer mortality associated with nifedipine in a large population of patients post-myocardial infarction." | 5.08 | Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction. ( Behar, S; Boyko, V; Goldbourt, U; Jonas, M; Mandelzweig, L; Reicher-Reiss, H, 1998) |
| "The administration of nifedipine, 30 mg/d, between 7 and 22 days after hospitalization for an acute myocardial infarction (Secondary Prevention Reinfarction Israel Nifedipine Trial study) showed no effect on subsequent mortality and morbidity." | 5.07 | Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. ( Behar, S; Goldbourt, U; Kaplinsky, E; Mandelzweig, L; Reicher-Reiss, H; Zion, M, 1993) |
| "Once-daily administration of amlodipine is a highly effective treatment for patients with angina pectoris." | 5.07 | Amlodipine in post-infarction angina. ( Taylor, SH, 1992) |
| "To ascertain whether predischarge arteriography is beneficial in patients with acute myocardial infarction treated with recombinant tissue-type plasminogen activator (rt-PA), heparin and aspirin, the outcome of 197 patients in the Thrombolysis in Myocardial Infarction (TIMI) IIA study assigned to conservative management and routine predischarge coronary arteriography (routine catheterization group) was compared with the outcome of 1,461 patients from the TIMI IIB study assigned to conservative management without routine coronary arteriography unless ischemia recurred spontaneously or on predischarge exercise testing (selective catheterization group)." | 5.07 | Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators. ( Babb, JD; Baim, DS; Braunwald, E; Chesebro, JH; Frederick, M; Gore, JM; Passamani, ER; Roberts, R; Rogers, WJ; Williams, DO, 1991) |
| "We performed a randomized study on patients undergoing elective coronary bypass grafting to examine whether postoperative infusion of nifedipine (n = 25) could reduce the incidence of isolated transient myocardial ischemia, myocardial infarction, or both." | 5.06 | Infusion of nifedipine after coronary artery bypass grafting decreases the incidence of early postoperative myocardial ischemia. ( Binder, TM; Coraim, F; Holzinger, C; Huber, S; Peschl, F; Schwarzacher, S; Seitelberger, R; Spatt, J; Weber, H; Zwölfer, W, 1990) |
| "We used spectral analysis of heart rate variability (HRV) to study the effects of the calcium channel blockers diltiazem and nifedipine and the beta-blocker metoprolol on the sympathetic nervous system in patients following myocardial infarction." | 5.06 | Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction. ( Bekheit, S; Craelius, W; el-Sakr, A; el-Sherif, N; Rasheed, Q; Tangella, M, 1990) |
| "14 CCUs in Israel participated in a double-blind, placebo controlled, randomized trial of nifedipine, 30 mg/day, for the secondary prevention of myocardial infarction (MI)." | 5.06 | [Nifedipine in secondary prevention after myocardial infarction. SPRINT Study Group]. ( , 1989) |
| "The efficacy of nifedipine in the prevention of post-infarction morbidity and mortality was evaluated in a double-blind clinical trial of 2276 survivors of acute myocardial infarction recruited from the cardiac departments of 14 Israeli hospitals." | 5.06 | Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group. ( , 1988) |
| "The haemodynamic impact of alpha- and beta-adrenoceptor blockade (labetalol) was compared with that of slow-calcium channel blockade (nifedipine) in 32 patients with sustained elevation of systemic arterial pressure (systolic blood pressure greater than 160; diastolic blood pressure greater than 95 mmHg) following a recent myocardial infarction (6-22 h)." | 5.06 | Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine. ( Hussain, M; Nelson, GI; Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP; Wilson, JA, 1988) |
| "In a double-blind placebo-controlled trial to study the effect of nifedipine on ventricular arrhythmias among patients with acute myocardial infarction, 434 patients with suspected myocardial infarction were randomized within 6 h from the onset of chest pain to treatment with nifedipine (p = 217) or placebo (p = 217)." | 5.06 | Effect of nifedipine on arrhythmias in the acute phase of myocardial infarction. ( Adgey, AA; MacKenzie, G; Walker, LJ, 1988) |
| "Over 30 months 9292 consecutive patients admitted to nine coronary care units with suspected myocardial infarction were considered for admission to a randomised double blind study comparing the effect on mortality of nifedipine 10 mg four times a day with that of placebo." | 5.06 | Trial of early nifedipine in acute myocardial infarction: the Trent study. ( Banks, DC; Birkhead, JS; Brooksby, IA; Burns-Cox, CJ; Hampton, JR; Hayes, MJ; Joy, MD; Malcolm, AD; Mather, HG; Wilcox, RG, 1986) |
| "To evaluate the protective effect of nifedipine on ischemic myocardium, in addition to thrombolytic therapy, a total of 149 patients with acute myocardial infarction were included in a double-blind controlled study in which they received 20 mg sublingual nifedipine (74 patients in group 1) or placebo (75 patients in group 2) in the emergency ward, either intracoronary nifedipine, 0." | 5.06 | Combination of calcium channel blocker and thrombolytic therapy in acute myocardial infarction. ( Erbel, R; Henrichs, KJ; Meinertz, T; Meyer, J; Olshausen, KV; Pop, T; Rupprecht, HJ; Schlürmann, W; Schuster, CJ; Treese, N, 1988) |
| "In a double blind placebo controlled trial, 434 patients with suspected myocardial infarction were randomised to treatment with nifedipine (n = 217) or placebo (n = 217) within six hours from the onset of chest pain." | 5.06 | Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction. ( Adgey, AA; MacKenzie, G; Walker, LJ, 1988) |
| "The influence of nifedipine on left ventricular ejection fraction, infarct size, and infarct expansion was studied in a prospective, double blind, randomised, placebo controlled trial in 132 patients with low risk acute myocardial infarction of less than 12 hours duration, defined by an initial left ventricular ejection fraction greater than 35% and clinical Killip class of less than or equal to II." | 5.06 | Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trial. ( Becker, LC; Chandra, NC; Flaherty, JT; Gottlieb, SH; Gottlieb, SO; Mellits, ED; Ouyang, P; Shapiro, EP; Townsend, SN; Weiss, JL, 1988) |
| "In a prospective, randomized trial of 28 patients with acute myocardial infarction nifedipine or diltiazem were administered intravenously and hemodynamic parameters and drug plasma levels measured for 24 hours." | 5.06 | [Hemodynamic effect of intravenous diltiazem and nifedipine in acute myocardial infarct. A randomized study]. ( Drexler, H; Hümmler, S; Just, H; Kasper, W; Meinertz, T; Zeiher, A, 1987) |
| "Seventeen post-myocardial infarction patients experiencing angina on effort performed 6 different exercise tests until they reached symptom-limited maximal level, 3 after placebo and 3 after oral administration of 10 mg of the Calcium antagonist, nifedipine, in a randomized, double blind, cross-over controlled study." | 5.06 | Assessment of exercise tolerance of cardiac patients by bicycle, treadmill and treadmill plus isometric exercise with and without nifedipine. ( Hämäläinen, H; Kallio, V; Pietilä, J; Vuori, I, 1987) |
| "This review critically evaluates the recently reported clinical trials involving the administration of nifedipine and verapamil after myocardial infarction and highlights the ongoing trials with diltiazem." | 5.06 | Current status of calcium channel blocking drugs after myocardial infarction. ( Moss, AJ, 1986) |
| "SPRINT was a double-blind, randomized placebo controlled multi-centre trial based in Israel, designed to test whether nifedipine 10 mg X 3 daily would reduce morbidity and mortality during 1 year follow-up in 2279 male and female survivors of acute myocardial infarction." | 5.06 | Calcium antagonists in secondary prevention after acute myocardial infarction: the Secondary Prevention Reinfarction Nifedipine Trial (SPRINT). ( Neufeld, HN, 1986) |
| "To define effects of nifedipine on regional metabolism in jeopardized myocardium we quantified accumulation of carbon-11 labeled palmitate ([11C]palmitate) in patients with acute myocardial infarction by positron emission tomography in a randomized, double-blind, placebo controlled study." | 5.06 | Enhancement of metabolism of jeopardized myocardium by nifedipine. ( Biello, DR; Geltman, EM; Jaffe, AS; Sobel, BE, 1987) |
| "In this single centre prospective, double blind study, 98 patients with suspected acute myocardial infarction (AMI) were randomized, within six hours, to nifedipine 10 mg (46 patients) or placebo (52 patients) both administered sublingually." | 5.06 | Effect of early treatment with nifedipine in suspected acute myocardial infarction. ( Branagan, JP; Collins, WC; Kelly, P; McCafferty, D; Walsh, K; Walsh, MJ, 1986) |
| "Twenty-six patients with acute myocardial infarction (mean delay time 6 hours after onset of symptoms) were randomized to control or nifedipine treatment (10 mg sublingually, followed by 10 mg every 6 hours for a total of 24 hours)." | 5.05 | Hemodynamic effects of sublingual nifedipine in acute myocardial infarction. ( Eichler, HG; Gordon, GD; Isaacs, S; Lloyd, EA; Mabin, TA; Opie, LH, 1984) |
| "Preliminary clinical and laboratory observations suggest that nifedipine might prevent progression of threatened myocardial infarction by reversing coronary spasm or might limit necrosis during the course of acute myocardial infarction." | 5.05 | Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. ( Morrison, J; Muller, JE; Pearle, DL; Roberts, R; Rosner, B; Rude, RE; Schneider, JF; Serfas, DH; Stone, PH; Turi, ZG, 1984) |
| "In a double-blind trial, 30 patients with suspected acute myocardial infarction with onset of symptoms within the previous 24 h were randomized to treatment with 10 mg nifedipine/placebo orally 4 times a day during hospitalization." | 5.05 | Hemodynamic and clinical findings after combined therapy with metoprolol and nifedipine in acute myocardial infarction. ( Emanuelsson, H; Herlitz, J; Hjalmarson, A; Holmberg, S; Waagstein, F; Waldenström, A; Waldenström, J, 1984) |
| "In a multicenter double-blind study, 227 patients with suspected acute myocardial infarction (AMI) were randomized within 12 hr from onset of symptoms to treatment with nifedipine (112 patients) or placebo (115 patients)." | 5.05 | Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial. ( Bathen, J; Drivenes, A; Frøland, GS; Kjekshus, JK; Landmark, K; Overskeid, K; Pedersen, TR; Rokseth, R; Sirnes, KE; Sirnes, PA, 1984) |
| "In 12 male patients with angiographically confirmed coronary heart disease and stable angina the antianginal effects of 50 mg Gallopamil have been studied in comparison with 10 mg Nifedipine and placebo." | 5.05 | [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo]. ( Drews, H; Hopf, R; Kaltenbach, M, 1984) |
| "To evaluate the hemodynamic effects of nifedipine on anginal patients during exercise in the upright position, a placebo (P) and 20 mg of nifedipine were administered in a double-blind random sequence to ten patients presenting with exertional angina and a healed myocardial infarction." | 5.05 | Acute effects of chewable nifedipine on hemodynamic responses to upright exercise in patients with prior myocardial infarction and effort angina. ( Angelino, PF; Baduini, G; Marra, S; Paolillo, V; Spadaccini, F, 1983) |
| "Fifty-seven consecutive patients with acute myocardial infarction (AMI), admitted to a coronary care unit (CCU) within 6 h from onset of symptoms were included in the study and randomly allocated to nifedipine treatment or placebo." | 5.05 | Complexity of enzyme release during acute myocardial infarction in a controlled study with early nifedipine treatment. ( Groth, T; Loogna, E; Mogensen, L; Sylvén, C, 1985) |
| "The absorption of nifedipine (10 mg) and haemodynamic response were studied in 10 patients with myocardial infarction before (Phase A) and after (Phase B) a standardized breakfast." | 5.05 | Effect of food ingestion on nifedipine absorption and haemodynamic response. ( Hirasawa, K; Kelly, DT; Roubin, G; Shen, WF; Shibata, J; Tateda, K, 1985) |
| " hypertension clinical trial databases for amlodipine (Norvasc) and nifedipine in the gastrointestinal therapeutic system (GITS) formulation (Procardia XL)." | 4.80 | Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients. ( Kloner, RA; Levenstein, M; Materson, BJ; Vetrovec, GW, 1998) |
| "Nifedipine administration for hypertensive emergencies can induce neurological and cardiac events due to abrupt hypotension." | 4.80 | Hypotension and coronary events on nifedipine: reassessing nifedipine safety. ( , 1998) |
| " Although nifedipine is highly effective against vasospastic angina, its use in threatened myocardial infarction or severe unstable angina is not supported by recent studies, unless combined with a beta-blocker." | 4.77 | Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials. ( Opie, LH, 1988) |
| "To examine the association between hospitalization for acute coronary syndromes and treatment with amlodipine or extended-release nifedipine in patients 65 years of age and older." | 3.74 | Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study. ( Bucci, C; Juurlink, DN; Mamdani, MM; Tu, JV, 2008) |
| "Although short-acting nifedipine does not prevent myocardial infarction (MI), calcium antagonists with a long half-life may be effective." | 3.73 | Calcium antagonists for secondary prevention of myocardial infarction: is there a need to shift from short-acting to long-acting types? ( Hayashi, T; Hirano, Y; Ishikawa, K; Kimura, A; Miyataka, M; Taniguchi, M; Taniwa, T, 2005) |
| "The effects of pretreatment with cariporide on myocardial infarction and ventricular arrhythmias in a rat model of ischemia/reperfusion were compared with those of nicorandil, propranolol, and nifedipine." | 3.72 | Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs. ( Beguier, B; Wajima, T; Yaguchi, M, 2004) |
| "The effect of nifedipine-retard (NR) (n=202) compared with that of non-CCB treatment (n=92) on the secondary prevention of myocardial infarction (MI) was retrospectively investigated in patients who had survived acute MI between 1987 and 1996." | 3.72 | Efficacy of calcium channel blocker in the secondary prevention of myocardial infarction--retrospective analysis of the 10-year prognosis or coronary thrombolysis-treated patients. ( Anazawa, T; Furuya, S; Kanmatsuse, K; Kawamata, H; Kikushima, K; Kushiro, T; Nagao, K; Sasanuma, T; Tachibana, E; Tani, S; Watanabe, I; Watanabe, K, 2004) |
| "The effects of SMP-300, an orally active, potent, and selective Na+/H+ exchange inhibitor, were evaluated and compared with those of nifedipine, propranolol, and nicorandil on three experimental angina models and on myocardial infarction in rats." | 3.71 | Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats. ( Matsui, K; Ohashi, N; Sasabe, M; Yamamoto, S, 2002) |
| " Nitroglycerin was named as first choice only for pulmonary oedema or myocardial infarction." | 3.70 | [Diagnostic and therapeutic procedures by doctors for patients in a hypertensive crisis. An inquiry in 56 internal medicine clinics]. ( Grieshaber, M; Schwietzer, G; Stahl, RA; Wenzel, UO, 1998) |
| "Calcium channel blockers were widely prescribed at hospital discharge to elderly patients with myocardial infarction between 1994 and 1995 (n = 51,921), the most commonly prescribed being diltiazem (n = 21,175), nifedipine (n = 12,670), amlodipine (n = 11,683), and verapamil (n = 3639)." | 3.70 | Calcium channel blockers and mortality in elderly patients with myocardial infarction. ( Cascio, WE; Chowdhury, MK; Crouse, JR; Jollis, JG; Massing, MW; Simpson, RJ; Smith, SC, 1999) |
| "A 34-year-old mother developed acute myocardial infarction (MI) 10 days postpartum while taking bromocriptine for ablactation." | 3.69 | Acute myocardial infarction in a healthy mother using bromocriptine for milk suppression. ( Hopp, L; Iffy, L; Weisse, AB, 1996) |
| "The effect of nifedipine on ventriculoarterial coupling was examined in 8 patients with old myocardial infarction who showed a depressed ejection fraction (37 +/- 7%)." | 3.69 | The effect of nifedipine on ventriculoarterial coupling in old myocardial infarction. ( Fujii, T; Hiro, T; Katayama, K; Kohno, M; Matsuzaki, M; Miura, T; Seki, K; Yano, M, 1996) |
| "Myocardial infarction induced by coronary occlusion (O model) and reperfusion (R model) and the effects of nitroglycerin (Nit), propranolol (Pro), lidocaine (Lid), nifedipine (Nif), and saline were studied in rats by image analysis and weighing methods." | 3.68 | [Image analysis of effects of 4 drugs on coronary occlusion and myocardial reperfusion injury]. ( Han, L; Tang, ZM, 1993) |
| "The impact of intravenous infusion of nifedipine and nitroglycerin on invasive central hemodynamic parameters and microcirculation was compared in 94 patients with acute myocardial infarction complicated by heart failure." | 3.68 | [Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin]. ( Gruzdev, AK; Kosminskiĭ, PG; Lazarev, IA; Magnitskiĭ, AV; Sidorenko, BA; Vaniev, SB; Vasechkin, SS, 1992) |
| "It has been shown, that antipyrine, nifedipine, diazepam pharmacokinetics changes in different ways after myocardial infarction." | 3.68 | [Pharmacokinetics of antipyrine, nifedipine and diazepam in experimental myocardial infarct]. ( Anan'ev, EA; Grek, OR; Kolpakov, MA; Sharapov, VI, 1992) |
| "The immunomodulatory effect of the lipid-reducing etofibrate, the calcium antagonist nifedipine and the immunosuppressive cyclosporine A was studied on in vitro cellular immune response in the presence of human aortic extract and of human LDL in 56 patients with acute myocardial infarction." | 3.68 | The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction. ( Geró, S; Horváth, M; Jósfay, A; Mezey, Z; Nánay, I; Varsányi, M, 1991) |
| "The efficacy of intravenous nifedipine was examined in 42 patients with acute myocardial infarction complicated by congestive heart failure." | 3.68 | [Use of intravenous nifedipine in the treatment of cardiac insufficiency in the acute period of myocardial infarction]. ( Gruzdev, AK; Kosminskiĭ, PG; Magnitskiĭ, AV; Sidorenko, BA; Vaniev, SB; Vasechkin, SS, 1991) |
| "Following multiple myocardial infarctions, a patient was treated with the calcium channel-blocking agent nifedipine." | 3.67 | Development of immune complex nephritis during treatment with the calcium channel-blocking agent nifedipine. ( Hall-Craggs, M; Light, PD; Peters, RW, 1984) |
| "The acute effect of nifedipine (Adalat, Bayer) was evaluated in 54 men with a history of transmural myocardial infarction." | 3.67 | Evaluation of the effect of nifedipine in men after myocardial infarction. ( Jedlicka, J; Kidéry, J; Málek, I; Nestával, A; Oppelt, A; Stanĕk, V, 1984) |
| "The ability of the two calcium-antagonists Verapamil and Nifedipine to reduce ventricular electrical instability following acute transient coronary artery occlusion and release and to prevent ventricular arrhythmias, particularly fibrillation, was evaluated on a total of 25 anaesthetized and artificially ventilated dogs." | 3.67 | [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion]. ( Bender, F; Brisse, B; Gülker, H; Thale, J, 1984) |
| "We describe two patients in whom spontaneous angina following acute myocardial infarction (postinfarction angina caused by coronary artery spasm) and worsening angina were successfully eliminated after clinical dosage of oral diltiazem, while marked sinus node suppression developed and temporary pacing was performed." | 3.67 | Elimination of unstable angina by diltiazem under temporary pacing. ( Imamura, T; Ishikawa, T; Koiwaya, Y; Tanaka, K, 1984) |
| "The haemodynamic dose-response effects of the slow-calcium channel blocker nicardipine were evaluated in fifteen male patients with uncomplicated acute myocardial infarction." | 3.67 | Haemodynamic effects of nicardipine in acute myocardial infarction. ( Frais, MA; Hafizullah, M; Jackson, NC; Reynolds, G; Silke, B; Taylor, SH; Verma, SP, 1984) |
| "We observed marked gingival hyperplasia, similar clinically and histologically to the hyperplasia caused by 5:5 sodium diphenylhydantoin (Dilantin) during the last 18 months in five patients treated by nifedipine." | 3.67 | Gingival hyperplasia caused by nifedipine--a preliminary report. ( Behar, S; Engelberg, IS; Kishon, Y; Ramon, Y, 1984) |
| "The use of nifedipine in patients with hypertension, heart failure, and acute myocardial infarction is discussed." | 3.67 | Nifedipine in hypertension and heart failure. ( Matsui, S; Murakami, E; Murakami, H; Takekoshi, N, 1984) |
| " We also describe the application of this technique to a study of nifedipine combined with reperfusion in experimental myocardial infarction." | 3.67 | Failure of nifedipine and reperfusion to reduce infarct size relative to region at risk as measured by NADH fluorophotography. ( Apstein, CS; Connelly, C; DeJong, D; Foster, E, 1984) |
| "The haemodynamic effects of nifedipine (20 mg sublingually) were studied in 40 patients with acute myocardial infarction within 18 h of the onset of symptoms." | 3.67 | Nifedipine following acute myocardial infarction--dependence of response on baseline haemodynamic status. ( Jackson, NC; Nelson, GI; Reynolds, GW; Silke, B; Taylor, SH; Verma, SP; Wilson, JA, 1987) |
| "The effects of the two calcium antagonists bepridil and nifedipine on induced ventricular tachyarrhythmias were studied by programmed electrical stimulation in 15 dogs, 4-8 days after myocardial infarction." | 3.67 | Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs. ( Aidonidis, I; Brachmann, J; Dembowsky, K; Kuebler, W; Seller, H, 1989) |
| "m-Nisoldipine iv 3, 5 and 10 micrograms/kg before coronary artery ligation markedly reduced the early ischemic arrhythmia in conscious rats." | 3.67 | [Effects of m-nisoldipine on ischemic arrhythmia in conscious rats]. ( An, RH; Fu, SX; Li, YS, 1989) |
| " Among 15 patients with coronary artery disease who had been treated with nisoldipine, onset of severe unstable angina was observed in 2 and evolution of acute myocardial infarction in 1 patient after abrupt withdrawal of nisoldipine therapy." | 3.67 | Calcium-blocker withdrawal phenomenon: increase in affinity of alpha 2 adrenoceptors for agonist as a potential mechanism. ( Lopez, LM; Mehta, J, 1986) |
| "The comparative effects of the calcium-antagonists gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, particularly ventricular fibrillation (VF), were assessed in a total of 40 mongrel dogs in two experimental preparations." | 3.67 | Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds. ( Bender, F; Gülker, H; Haverkamp, W; Hindricks, G, 1987) |
| "Twelve male patients age 36-66, 8 on clinical doses of beta blocker, with old transmural myocardial infarction underwent rest and matched workload exercise before and 30 min after 20 mg sublingual nifedipine during cardiac catheterization." | 3.67 | Acute hemodynamic effects of nifedipine during supine exercise in patients with prior myocardial infarction. ( Cha, SD; MacMillan, RM; Maranhao, V, 1986) |
| "To examine whether nicardipine, a dihydropyridine derivative, limits size of myocardial infarction, and to compare the protective effects of nicardipine administered before and early and late after coronary artery occlusion, 99mTc-labeled albumin microspheres were injected into the left atrium during 5 min temporary coronary artery occlusion to determine the extent of the hypoperfused zone (the area at risk)." | 3.67 | Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. ( Endo, T; Fujita, S; Hayakawa, H; Iida, N; Kikuchi, K; Kiuchi, K; Nejima, J; Okumura, H, 1986) |
| "In conclusion, we observed first that nifedipine is highly efficacious in preventing the coronary vasospasm of Prinzmetal's variant angina." | 3.66 | Nifedipine therapy for coronary vasospasm. ( Antman, EM; Muller, JE; Stone, PH, 1983) |
| " During hospitalization all patients were treated with calcium antagonists (Nifedipine 10/20 mg every six hours) and/or nitrates (2% nitroglycerin ointment 2 inches every six/four hours) with one death (occurring after coronary arteriography) and eleven non-fatal myocardial infarctions." | 3.66 | [Angina at rest. Clinical, electrocardiographic and angiographic observations in 107 patients]. ( Ardissino, D; Bobba, P; Bramucci, E; Casali, PM; De Servi, S; Falcone, C; Martinelli, L; Minzioni, G; Mussini, A; Specchia, G; Viganò, M, 1980) |
| "Nitroglycerin ointment and nifedipine were used concurrently for vasodilator therapy in 10 patients with acute myocardial infarction." | 3.66 | Hemodynamic effects of concomitant nitroglycerin ointment and nifedipine treatment in acute myocardial infarction. ( Kanaya, H; Mori, K; Ohka, T; Onoe, T, 1982) |
| "The efficacy of nifedipine in relieving recurrent ischemic episodes following acute myocardial infarction was studied in 11 patients a mean of 9." | 3.66 | Nifedipine therapy for recurrent ischemic pain following myocardial infarction. ( Muller, JE; Stone, PH, 1982) |
| "In consideration of the results of experimental studies indicating that nifedipine, a vasodilating calcium antagonist with little inotropic or electrophysiological effects, increases coronary flow to both normal and ischemic zones potentially rendering protection of ischemic myocardium as well as the results of clinical studies in patients with angina pectoris, this pilot study was carried out in patients with acute myocardial infarction to evaluate the clinical, hemodynamic and electrophysiological responses." | 3.66 | Nifedipine and acute myocardial infarction. ( Henry, PD; Jaffe, AS; Roberts, R; Sobel, BE, 1981) |
| "The intravenous administration of either nifedipine (in doses of 5-50 microgram/kg), or nisoldipine (5-1000 microgram/kg) markedly reduced, or abolished, the serious ventricular arrhythmias (tachycardia and fibrillation) that result from acute coronary artery artery ligation in pentobarbitone-anaesthetized rats." | 3.66 | Calcium antagonists prevent early post-infarction ventricular fibrillation. ( Fagbemi, O; Parratt, JR, 1981) |
| "The acute haemodynamic effects of nifedipine (10 mg sublingually) and isosorbide dinitrate (5 mg sublingually) were compared in 13 patients with heart failure due to acute myocardial infarction." | 3.66 | Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction. ( Bracchetti, D; Cantelli, I; Naccarella, F; Pavesi, PC, 1981) |
| "10 patients recovering from acute myocardial infarction with stable symptomatology, underwent 3 subsequent ergometric trials: the first, basic, the second, after one month of practice on an ergometer bicycle and the third, with a longer period of training, after acute administration of nifedipine." | 3.66 | [The effects of physical training and nifedipine on patients recovering from acute myocardial infarction (author's transl)]. ( De Rosa, L; Greco, V; Latini, S; Matteoli, S; Trappolini, M; Volpe, N, 1981) |
| "The effectiveness of nifedipine in treating angina pectoris at rest was evaluated in 14 patients with frequent ischemic episodes associated with S-T segment elevation or depression." | 3.66 | Treatment of angina at rest with nifedipine: a short-term controlled study. ( Bobba, P; Chimienti, M; Medici, A; Previtali, M; Ray, M; Salerno, JA; Specchia, G; Tavazzi, L, 1980) |
| "The hemodynamic effects of a single oral dose of 20 mg of nifedipine were studied in 21 stable patients after an acute myocardial infarction before withdrawal of Swan-Ganz and intra-arterial catheters." | 3.66 | Hemodynamic effects of a single oral dose of nifedipine following acute myocardial infarction. ( Debaisieux, JC; Mizgala, HF; Theroux, P; Waters, DD, 1980) |
| "Nineteen patients in the acute stage of transmural myocardial infarction were given 20 mg nifedipine orally under haemodynamic control." | 3.66 | [Nifedipine in acute myocardial infarction (author's transl)]. ( Beck, OA; Halilović, E; Hochrein, H; Oeff, M, 1980) |
| "The hemodynamic effects of nitroglycerin and nifedipin and the application of both substances during a long term training program in patients with angina pectoris, myocardial infarction, and myocardial dysfunction (=48) were studied." | 3.66 | [Use of nifedipine and nitroglycerin during exercise therapy in patients with myocardial infarct. Clinical and hemodynamic studies]. ( Schenk, KE, 1978) |
| "The development of heart failure is uncommon in patients with stable angina, and even less so in the absence of an obvious precipitating factor." | 2.73 | The development of heart failure in patients with stable angina pectoris. ( de Brouwer, S; Erik Otterstad, J; Kirwan, BA; Lubsen, J; Poole-Wilson, PA; Sutton, GC; Vokó, Z, 2007) |
| "Frequent and recurrent ventricular premature beats (VPB's) are considered to be associated with a higher risk of sudden cardiac death, particularly for survivors of myocardial infarction (MI)." | 2.67 | Analysis of premature ventricular counts in long term ECG following myocardial infarction. ( Cohen, A; Laor, A, 1992) |
| "Thus, remediable coronary vasospasm is not likely to be a major cause of post infarction ischemia in patients with nontransmural infarction." | 2.66 | Chest pain after nontransmural infarction: the absence of remediable coronary vasospasm. ( Biello, DR; Eisenberg, PR; Geltman, EM; Jaffe, AS; Lee, RG, 1985) |
| "Nifedipine is a calcium antagonist with established anti-vasospastic action in man and, possibly cardioprotective effects during ischaemia." | 2.65 | Acute myocardial ischaemia: what information can be expected in the near future from ongoing clinical trials with nifedipine? ( Hugenholtz, PG; Lubsen, J, 1983) |
| "In 28 patients with unstable angina pectoris biplane coronary angiography was performed in the acute stage." | 2.65 | [Dynamics of critical stenosis in patients with unstable angina pectoris]. ( Karsch, KR; Niemczyk, P; Seipel, L; Voelker, W, 1984) |
| "Amiodarone is a potent coronary vasodilator; it has alpha and beta receptor-antagonist activity and is well-known for its marked antiarrhythmic efficacy." | 2.65 | The value of amiodarone for the treatment of unstable angina. ( Bertholet, M; Demoulin, JC; Hastir, F; Kulbertus, HE; Renier, J, 1983) |
| "Failure of medical treatment (defined as sudden death, myocardial infarction, or bypass surgery within four months) occurred in 43 of 70 patients given placebo and in 30 of 68 given nifedipine." | 2.65 | Nifedipine in unstable angina: a double-blind, randomized trial. ( Achuff, SC; Baughman, KL; Becker, LC; Bulkley, BH; Flaherty, JT; Gerstenblith, G; Kallman, CH; Llewellyn, M; Mellits, ED; Ouyang, P; Weisfeldt, ML; Weiss, JL, 1982) |
| " These differences can be attributed at least in part to the low catecholamine profile of verapamil and the marked rapid adrenergic activation with short-acting nifedipine, which could also explain the adverse effects found when this agent is given to patients with acute coronary syndromes." | 2.40 | Calcium channel blockers for hypertension: dissecting the evidence for adverse effects. ( Opie, LH, 1997) |
| " The interpretation of the results of these studies and their application to clinical practice requires an understanding of study design constraints, conflicting results and limitations in extrapolating study findings to other dosage strengths, formulations or agents within the calcium channel antagonist class." | 2.40 | Calcium channel antagonists: morbidity and mortality--what's the evidence? ( Parra, D; Straka, RJ; Swanson, AL, 1998) |
| " The reported adverse effect profile for each of these drugs varies, but tends to hold true to drug class and are typified by the adverse reactions reported for nifedipine and amlodipine (dihydropyridines), diltiazem (benzothiazepines) and verapamil (phenylalkylamines)." | 2.39 | A comparative review of the adverse effects of calcium antagonists. ( Dougall, HT; McLay, J, 1996) |
| "Nifedipine has been demonstrated to be no better than placebo both during and after an acute myocardial infarction." | 2.38 | Calcium antagonists and myocardial infarction. ( Hansen, JF, 1991) |
| "Pretreatment with verapamil reduced the size of these subendocardial infarcts from 34 +/- 8 to 8 +/- 3% of the ischemic circumflex vascular bed (anatomic area at risk)." | 2.37 | Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction. ( Jennings, RB; Reimer, KA, 1985) |
| "Nifedipine generally has little depressant action in this setting and usually improves cardiac function, especially if the sympathetic reflexes are intact." | 2.37 | Use of calcium antagonists in ventricular dysfunction. ( Josephson, MA; Singh, BN, 1985) |
| "Treatment with nifedipine can safely be combined with administration of a beta receptor blocking agent." | 2.36 | Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. ( Henry, PD, 1980) |
| "Case 3." | 1.46 | Added value of sending photograph in diagnosing a medical disease declared at sea: experience of the French Tele-Medical Assistance Service. ( Bounes, V; Dehours, E; Roucolle, P; Roux, P; Saccavini, A, 2017) |
| "Acute myocardial infarction is characterized by a more pronounced rise in plasma ANP concentration in hypertensive patients than in those without a history of hypertension." | 1.29 | Elevated plasma atrial natriuretic peptide concentrations in hypertensive patients with acute myocardial infarction. ( Górecki, A; Ignatowska-Switalska, H; Januszewicz, A; Kochanowski, J; Lapiński, M; Opolski, G; Stolarz, P; Słomka, K; Wocial, B, 1995) |
| "We studied seven patients with Prinzmetal's angina and three patients with unstable angina pectoris type III (according to the criteria of Conti) during and after a spontaneous attack of angina pectoris by two-dimensional echocardiography." | 1.28 | [Echocardiography detection of reversible regional disorders of contraction in patients with unstable angina pectoris and Prinzmetal angina during an attack]. ( Geibel, A; Hofmann, T; Just, H; Kasper, W; Meinertz, T; Wollschläger, H, 1989) |
| "Amlodipine is a dihydropyridine derivative belonging to the group of pharmacologic calcium entry blocking agents and is characterized as having a slow onset and relatively long duration of action with minimal effects on cardiac electrophysiology and myocardial contractility." | 1.28 | Cardioprotective effects of amlodipine in the ischemic-reperfused heart. ( Hoff, PT; Lucchesi, BR; Tamura, Y, 1989) |
| "Patients with unstable angina pectoris who remain symptomatic at rest after hospitalization are at increased risk of death or myocardial infarction." | 1.27 | Adjunctive nifedipine therapy in high-risk, medically refractory, unstable angina pectoris. ( Blaustein, AS; Heller, GV; Kolman, BS, 1983) |
| "Nicardipine treatment significantly modified the general haemodynamic responses to LAD ligation particularly in maintaining a low LV systolic pressure and inhibiting elevation of LV end diastolic pressure." | 1.27 | The beneficial effect of nicardipine on the healing of myocardial infarcts in dogs. ( Alps, BJ; Calder, C; Scott-Park, FM; Wilson, A, 1983) |
| "Nifedipine was infused intravenously for 5 hr beginning 15 min (n = 9) and 3 hr (n = 6) after permanent occlusion of the midcircumflex coronary artery and compared with early and delayed vehicle treatment (controls; n = 9)." | 1.27 | Protective effect of early and late treatment with nifedipine during myocardial infarction in the conscious dog. ( Becker, LC; Hutchins, GM; Melin, JA, 1984) |
| "Nifedipine was added to the reservoir and 0." | 1.27 | The protective effects of nifedipine in the isolated cat heart. ( Lefer, AM; Okamatsu, S, 1983) |
| "Nisoldipine is a potent peripheral and coronary vasodilator free of major myocardial depressant effects after acute intravenous administration." | 1.27 | Coronary and systemic hemodynamic effects of intravenous nisoldipine. ( De Feyter, PJ; Hugenholtz, PG; Serruys, PW; Soward, AL, 1986) |
| "Nifedipine is an effective agent for the treatment of postinfarction heart failure accompanied with high peripheral resistance." | 1.27 | [Use of nifedipine for treating heart failure in the subacute period of myocardial infarct in patients over 60]. ( Chistova, VS; Glezer, MG; Iakovlev, SV; Lazutin, VK; Sergeeva, EV, 1987) |
| " The equi-effective dosage was 0." | 1.27 | Comparison of the acute hemodynamic response to intravenous nisoldipine (Bay k 5552) and intravenous nifedipine for left ventricular dysfunction secondary to myocardial infarction. ( Aschenberg, W; Bleifeld, W; Clausen, A; Fehr, A; Nienaber, CA; Spielmann, RP, 1987) |
| "Nifedipine was discontinued in 3 patients because of hypotension (SBP less than 90), rapid atrial fibrillation, and complete heart block in one patient each." | 1.27 | Nifedipine infusion in acute myocardial infarction: experience in twelve patients. ( Barnett, DB; Bing, RF; Heagerty, AM; Pohl, JE; Walley, TJ; Woods, KL, 1987) |
| "Confusion and sleep disorders constitute 8 cases." | 1.27 | Nifedipine--a survey of adverse effects. Four years' reporting in Sweden. ( Myrhed, M; Wiholm, BE, 1986) |
| " Nicardipine given by three different dosing schedules to baboons markedly limited myocardial infarction over a 6 h period of LAD occlusion." | 1.27 | Nicardipine in models of myocardial infarction. ( Alps, BJ; Calder, C; Wilson, A, 1985) |
| "Nifedipine has been proposed as an agent to preserve viability and function of ischemic myocardium." | 1.26 | The effects of nifedipine on myocardial blood flow and contraction during ischemia in the dog. ( Agarwal, JB; Banka, VS; Bodenheimer, MM; Hattori, S; Helfant, RH; Weintraub, WS, 1982) |
| "Myocardial infarction was produced by a 2-hour occlusion and reperfusion of the distal third of the left anterior descending coronary artery in control dogs, FR 7534-treated dogs and FR 7534-treated dogs with a constant aortic blood pressure." | 1.26 | Reduction of myocardial infarct size by the calcium antagonist fr 7534. ( Brooks, HL; Gross, GJ; Meils, CM; Warltier, DC, 1981) |
| "Krypton-81m (81mKr) was infused constantly into the aortic sinuses." | 1.26 | The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs. ( Fox, K; Horlock, P; Klein, M; Pratt, T; Selwyn, AP; Welman, E, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 213 (63.58) | 18.7374 |
| 1990's | 99 (29.55) | 18.2507 |
| 2000's | 16 (4.78) | 29.6817 |
| 2010's | 5 (1.49) | 24.3611 |
| 2020's | 2 (0.60) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HW | 1 |
| Huang, CC | 1 |
| Leu, HB | 1 |
| Lin, YJ | 1 |
| Teragawa, H | 1 |
| Oshita, C | 1 |
| Ueda, T | 1 |
| Dehours, E | 1 |
| Saccavini, A | 1 |
| Roucolle, P | 1 |
| Roux, P | 1 |
| Bounes, V | 1 |
| Meredith, PA | 2 |
| Lloyd, SM | 2 |
| Ford, I | 2 |
| Elliott, HL | 2 |
| Bucci, C | 1 |
| Mamdani, MM | 1 |
| Juurlink, DN | 1 |
| Tu, JV | 1 |
| Vokó, Z | 3 |
| Danchin, N | 1 |
| de Brouwer, S | 2 |
| Kirwan, BA | 3 |
| Poole-Wilson, PA | 3 |
| Lubsen, J | 8 |
| Güvenç, TS | 1 |
| Gürkan, U | 1 |
| Güzelburç, O | 1 |
| Ilhan, E | 1 |
| Altay, S | 1 |
| Novikova, NA | 1 |
| Wajima, T | 1 |
| Beguier, B | 1 |
| Yaguchi, M | 1 |
| Feng, QZ | 1 |
| Li, TD | 1 |
| Wang, ZX | 1 |
| Yi, J | 1 |
| Wang, L | 1 |
| Yang, TS | 1 |
| Meng, J | 1 |
| Tani, S | 1 |
| Watanabe, I | 1 |
| Nagao, K | 1 |
| Kikushima, K | 1 |
| Watanabe, K | 1 |
| Anazawa, T | 1 |
| Kawamata, H | 1 |
| Tachibana, E | 1 |
| Furuya, S | 1 |
| Sasanuma, T | 1 |
| Kushiro, T | 1 |
| Kanmatsuse, K | 1 |
| Cleland, JG | 1 |
| Huan Loh, P | 1 |
| Freemantle, N | 1 |
| Clark, AL | 1 |
| Coletta, AP | 1 |
| Clayton, TC | 1 |
| Pocock, SJ | 1 |
| Fox, KA | 1 |
| Taniwa, T | 1 |
| Miyataka, M | 2 |
| Kimura, A | 3 |
| Taniguchi, M | 1 |
| Hirano, Y | 1 |
| Hayashi, T | 2 |
| Ishikawa, K | 3 |
| Messerli, FH | 4 |
| Staessen, JA | 1 |
| Sutton, GC | 1 |
| Erik Otterstad, J | 1 |
| Yui, Y | 1 |
| Shinoda, E | 1 |
| Kodama, K | 1 |
| Hirayama, A | 1 |
| Nonogi, H | 1 |
| Haze, K | 1 |
| Sumiyoshi, T | 1 |
| Hosoda, S | 1 |
| Kawai, C | 1 |
| Geddes, JS | 1 |
| Adgey, AA | 3 |
| Pantridge, JF | 1 |
| Demoulin, JC | 2 |
| Bertholet, M | 2 |
| Chevigne, M | 1 |
| Legrand, V | 1 |
| Renier, J | 2 |
| Soumagne, D | 1 |
| Soyeur, D | 1 |
| Limet, R | 1 |
| Kulbertus, H | 1 |
| Anastassiades, C | 1 |
| Ziacchi, V | 1 |
| Rossi, A | 1 |
| Lomanto, B | 1 |
| Stone, PH | 4 |
| Turi, ZG | 2 |
| Muller, JE | 5 |
| Opie, LH | 5 |
| Thandroyen, FT | 1 |
| Hamm, CW | 2 |
| Muller, CA | 1 |
| Lloyd, EA | 2 |
| Gordon, D | 1 |
| Parratt, JR | 2 |
| Blaustein, AS | 1 |
| Heller, GV | 1 |
| Kolman, BS | 1 |
| Gordon, GD | 1 |
| Mabin, TA | 1 |
| Isaacs, S | 1 |
| Eichler, HG | 1 |
| Beck, OA | 2 |
| Geisler, S | 1 |
| Hochrein, H | 2 |
| Lichtlen, PR | 3 |
| Hollman, J | 1 |
| Austin, GE | 1 |
| Gruentzig, AR | 1 |
| Douglas, JS | 1 |
| King, SB | 1 |
| Wu, GL | 2 |
| Chen, SG | 2 |
| Jia, DL | 2 |
| Cao, EH | 1 |
| Zhang, DM | 1 |
| Henry, PD | 2 |
| Braunwald, E | 2 |
| Gough, WB | 1 |
| Zeiler, RH | 1 |
| El-Sherif, N | 2 |
| Castaigne, A | 1 |
| Palsky, E | 1 |
| Benghozi, R | 1 |
| Ledouarin, B | 1 |
| Hugenholtz, PG | 7 |
| Morrison, J | 1 |
| Rude, RE | 1 |
| Rosner, B | 1 |
| Roberts, R | 5 |
| Pearle, DL | 2 |
| Schneider, JF | 1 |
| Serfas, DH | 1 |
| Hall-Craggs, M | 1 |
| Light, PD | 1 |
| Peters, RW | 1 |
| Emanuelsson, H | 1 |
| Herlitz, J | 1 |
| Hjalmarson, A | 1 |
| Holmberg, S | 1 |
| Waagstein, F | 1 |
| Waldenström, A | 1 |
| Waldenström, J | 1 |
| Sirnes, PA | 1 |
| Overskeid, K | 1 |
| Pedersen, TR | 1 |
| Bathen, J | 1 |
| Drivenes, A | 1 |
| Frøland, GS | 1 |
| Kjekshus, JK | 1 |
| Landmark, K | 1 |
| Rokseth, R | 1 |
| Sirnes, KE | 1 |
| Hopf, R | 1 |
| Drews, H | 1 |
| Kaltenbach, M | 2 |
| Seu, V | 1 |
| Abrile, PG | 1 |
| Boero, E | 1 |
| Magaia, O | 1 |
| Mocini, A | 1 |
| Castrignano, A | 1 |
| Maffei, P | 1 |
| Perugini, P | 1 |
| Livi, A | 1 |
| Antman, EM | 1 |
| Wester, HA | 1 |
| Mouselimis, N | 1 |
| Karsch, KR | 2 |
| Niemczyk, P | 1 |
| Voelker, W | 2 |
| Seipel, L | 1 |
| Bornstein, A | 1 |
| Dalal, P | 1 |
| Tischler, J | 1 |
| Novack, S | 1 |
| Michaelson, S | 1 |
| Málek, I | 2 |
| Oppelt, A | 1 |
| Nestával, A | 1 |
| Kidéry, J | 1 |
| Jedlicka, J | 1 |
| Stanĕk, V | 2 |
| Gülker, H | 2 |
| Thale, J | 1 |
| Brisse, B | 1 |
| Bender, F | 2 |
| Ishikawa, T | 1 |
| Imamura, T | 1 |
| Koiwaya, Y | 1 |
| Tanaka, K | 1 |
| Siebert, J | 2 |
| Skarzyński, P | 2 |
| Yellon, DM | 3 |
| Downey, JM | 3 |
| Hearse, DJ | 3 |
| Silke, B | 3 |
| Verma, SP | 3 |
| Hafizullah, M | 1 |
| Reynolds, G | 1 |
| Frais, MA | 1 |
| Jackson, NC | 2 |
| Taylor, SH | 4 |
| Urbaniuk, KG | 1 |
| Mazurets, AF | 1 |
| Volgina, AS | 1 |
| Bott-Silverman, C | 1 |
| Heupler, FA | 1 |
| Ramon, Y | 1 |
| Behar, S | 12 |
| Kishon, Y | 2 |
| Engelberg, IS | 1 |
| Hastir, F | 1 |
| Kulbertus, HE | 1 |
| Bando, S | 1 |
| Kakutani, A | 1 |
| Shinomiya, H | 1 |
| Noda, T | 1 |
| Minezono, K | 1 |
| Mori, H | 2 |
| Yamasawa, I | 1 |
| Nohara, Y | 1 |
| Konno, S | 1 |
| Nagai, Y | 1 |
| Yaoita, N | 1 |
| Kaneko, Y | 1 |
| Takahashi, H | 1 |
| Takanashi, M | 1 |
| Abe, T | 1 |
| Hachiya, T | 1 |
| Sassa, H | 1 |
| Alps, BJ | 3 |
| Calder, C | 3 |
| Wilson, A | 3 |
| Scott-Park, FM | 1 |
| Melin, JA | 1 |
| Becker, LC | 3 |
| Hutchins, GM | 1 |
| Madias, JE | 2 |
| O'Connor, WH | 1 |
| Murakami, E | 1 |
| Takekoshi, N | 1 |
| Matsui, S | 1 |
| Murakami, H | 1 |
| Foster, E | 1 |
| DeJong, D | 1 |
| Connelly, C | 1 |
| Apstein, CS | 1 |
| Banka, N | 1 |
| Anand, IS | 1 |
| Chakravarti, RN | 1 |
| Sharma, PL | 1 |
| Staffurth, JS | 1 |
| Emery, P | 1 |
| Genovese, A | 1 |
| Chiariello, M | 1 |
| Latte, S | 1 |
| de Alfieri, W | 1 |
| Cacciapuoti, AA | 1 |
| Condorelli, M | 1 |
| Casali, PM | 1 |
| De Servi, S | 1 |
| Ardissino, D | 1 |
| Martinelli, L | 1 |
| Mussini, A | 1 |
| Bramucci, E | 1 |
| Falcone, C | 1 |
| Minzioni, G | 1 |
| Viganò, M | 1 |
| Specchia, G | 2 |
| Bobba, P | 2 |
| Robson, RH | 1 |
| Vishwanath, MC | 1 |
| Serruys, PW | 6 |
| van den Brand, M | 3 |
| Hooghoudt, TE | 1 |
| Simoons, ML | 4 |
| Fioretti, P | 3 |
| Ruiter, J | 1 |
| Fels, PW | 2 |
| Wijns, W | 1 |
| Balakumaran, K | 1 |
| Reiber, JH | 2 |
| Lie, P | 1 |
| Mori, K | 1 |
| Onoe, T | 1 |
| Ohka, T | 1 |
| Kanaya, H | 1 |
| Dipalma, JR | 1 |
| Marra, S | 1 |
| Paolillo, V | 1 |
| Baduini, G | 1 |
| Spadaccini, F | 1 |
| Angelino, PF | 1 |
| Okamatsu, S | 1 |
| Lefer, AM | 1 |
| Michels, HR | 1 |
| Brower, RW | 1 |
| Théroux, P | 4 |
| Waters, DD | 4 |
| Debaisieux, JC | 2 |
| Szlachcic, J | 2 |
| Mizgala, HF | 2 |
| Bourassa, MG | 1 |
| Chaitman, BR | 1 |
| Hanson, JS | 1 |
| Gerstenblith, G | 1 |
| Ouyang, P | 2 |
| Achuff, SC | 1 |
| Bulkley, BH | 1 |
| Mellits, ED | 2 |
| Baughman, KL | 1 |
| Weiss, JL | 2 |
| Flaherty, JT | 2 |
| Kallman, CH | 1 |
| Llewellyn, M | 1 |
| Weisfeldt, ML | 1 |
| Singh, BN | 2 |
| Weintraub, WS | 1 |
| Hattori, S | 1 |
| Agarwal, JB | 1 |
| Bodenheimer, MM | 1 |
| Banka, VS | 1 |
| Helfant, RH | 2 |
| Geary, GG | 1 |
| Smith, GT | 1 |
| Suehiro, GT | 1 |
| McNamara, JJ | 1 |
| Schwartz, A | 1 |
| Miller, D | 1 |
| Majid, PA | 1 |
| De Jong, J | 1 |
| Daniel Riesco, C | 1 |
| Aros Borau, F | 1 |
| Cordo Mollar, JC | 1 |
| Penas Lado, M | 1 |
| Gebauerová, M | 1 |
| Niederle, P | 1 |
| De Feyter, PJ | 2 |
| van Eenige, MJ | 1 |
| de Jong, JP | 1 |
| van der Wall, EE | 2 |
| Dighton, DH | 1 |
| Roos, JP | 2 |
| Jaffe, AS | 3 |
| Sobel, BE | 2 |
| Ganguly, PK | 1 |
| Srivastava, LM | 1 |
| Bora, PS | 1 |
| Gupta, MP | 1 |
| Seth, SD | 1 |
| Nayler, WG | 1 |
| Meils, CM | 1 |
| Gross, GJ | 3 |
| Brooks, HL | 1 |
| Warltier, DC | 3 |
| Fagbemi, O | 1 |
| Franciosa, JA | 1 |
| Cantelli, I | 1 |
| Pavesi, PC | 1 |
| Naccarella, F | 1 |
| Bracchetti, D | 1 |
| Greco, V | 1 |
| Trappolini, M | 1 |
| Volpe, N | 1 |
| De Rosa, L | 1 |
| Latini, S | 1 |
| Matteoli, S | 1 |
| Terrosu, P | 1 |
| Sannia, L | 1 |
| Frau, G | 1 |
| Piras, L | 1 |
| Ibba, GV | 1 |
| Nicita-Mauro, V | 1 |
| Barbera, N | 1 |
| Ciraolo, O | 1 |
| Carrozza, G | 1 |
| Nicotina, PA | 1 |
| Grosso, M | 1 |
| Lasco, A | 1 |
| Squadrito, G | 1 |
| Previtali, M | 1 |
| Salerno, JA | 1 |
| Tavazzi, L | 1 |
| Ray, M | 1 |
| Medici, A | 1 |
| Chimienti, M | 1 |
| Oeff, M | 1 |
| Halilović, E | 1 |
| Sant'Anna, JR | 1 |
| Lucchese, FA | 1 |
| Mattos, EC | 1 |
| Wagner, EM | 1 |
| Rodrigues, R | 1 |
| Mazur, NA | 2 |
| Pavlova, TS | 2 |
| Vasil'eva, NN | 2 |
| Kul'ginskaia, IV | 2 |
| Tanne, D | 1 |
| Reicher-Reiss, H | 9 |
| Boyko, V | 5 |
| Górecki, A | 1 |
| Januszewicz, A | 1 |
| Opolski, G | 1 |
| Lapiński, M | 1 |
| Wocial, B | 1 |
| Ignatowska-Switalska, H | 1 |
| Słomka, K | 1 |
| Kochanowski, J | 1 |
| Stolarz, P | 1 |
| Goldbourt, U | 8 |
| Barbash, G | 1 |
| Modan, B | 1 |
| Feinberg, MS | 1 |
| Mandelzweig, L | 6 |
| Zion, M | 3 |
| Kaplinsky, E | 7 |
| Manoria, PC | 1 |
| Zhu, JR | 1 |
| Cai, QS | 1 |
| Han, L | 1 |
| Tang, ZM | 1 |
| Rabinowitz, B | 1 |
| Abinader, E | 1 |
| Agmon, J | 2 |
| Friedman, Y | 1 |
| Palant, A | 1 |
| Knothe, C | 1 |
| Boldt, J | 1 |
| Zickmann, B | 1 |
| Ballesteros, M | 1 |
| Häufler, G | 1 |
| Bruns, F | 1 |
| Hempelmann, G | 1 |
| Klingenheben, T | 1 |
| Zabel, M | 1 |
| Just, H | 3 |
| Hohnloser, SH | 1 |
| Ottman, EH | 1 |
| Gall, SA | 1 |
| Oberpichler-Schwenk, H | 1 |
| van Zwieten, PA | 1 |
| Tijssen, JG | 4 |
| Lie, KI | 2 |
| de Leeuw, PW | 1 |
| Hopp, L | 1 |
| Weisse, AB | 1 |
| Iffy, L | 1 |
| Marwick, C | 1 |
| Hassall, JJ | 1 |
| Rafflenbeul, W | 2 |
| Seki, K | 1 |
| Katayama, K | 1 |
| Hiro, T | 1 |
| Yano, M | 1 |
| Miura, T | 1 |
| Kohno, M | 1 |
| Fujii, T | 1 |
| Matsuzaki, M | 1 |
| Purcell, H | 1 |
| Mulcahy, D | 2 |
| Rosendaal, FR | 1 |
| Psaty, BM | 1 |
| Furberg, CD | 1 |
| Rayo Llerena, I | 1 |
| Marín Huerta, E | 1 |
| Cohen, JD | 1 |
| Mackay, JA | 1 |
| Sever, PS | 1 |
| Schulz, J | 1 |
| Schmidt, J | 1 |
| Rück, W | 1 |
| Dougall, HT | 1 |
| McLay, J | 1 |
| Baldassarre, S | 1 |
| Unger, P | 2 |
| Renard, M | 1 |
| Leor, J | 1 |
| Battler, A | 1 |
| Killip, T | 1 |
| Davies, RF | 1 |
| Goldberg, AD | 1 |
| Forman, S | 1 |
| Pepine, CJ | 2 |
| Knatterud, GL | 1 |
| Geller, N | 1 |
| Sopko, G | 1 |
| Pratt, C | 1 |
| Deanfield, J | 1 |
| Conti, CR | 1 |
| Smielak-Korombel, W | 1 |
| Kulon, I | 1 |
| Stojek, A | 1 |
| Dryglas, D | 1 |
| Gawor, M | 1 |
| Nakai, S | 1 |
| Takenaka, T | 3 |
| Kanamasa, K | 2 |
| Hama, J | 1 |
| Ogawa, I | 1 |
| Yamamoto, T | 1 |
| Oyaizu, M | 1 |
| Yamamoto, K | 1 |
| Yabushita, H | 1 |
| Katori, R | 1 |
| Thompson, PL | 1 |
| Langton, PE | 1 |
| Waters, D | 1 |
| Ottervanger, JP | 1 |
| Wilson, JH | 1 |
| Stricker, BH | 1 |
| Leitch, JW | 1 |
| McElduff, P | 1 |
| Dobson, A | 1 |
| Heller, R | 1 |
| Głuszek, J | 1 |
| Pawlaczyk-Gabriel, K | 1 |
| Straka, RJ | 1 |
| Swanson, AL | 1 |
| Parra, D | 1 |
| Tomiyama, H | 1 |
| Watanabe, G | 1 |
| Siojima, K | 1 |
| Nishikawa, E | 1 |
| Nakayama, T | 1 |
| Yamamoto, A | 1 |
| Ishikawa, Y | 1 |
| Yoshida, H | 1 |
| Doba, N | 1 |
| Wenzel, UO | 1 |
| Stahl, RA | 1 |
| Grieshaber, M | 1 |
| Schwietzer, G | 1 |
| Kloner, RA | 2 |
| Vetrovec, GW | 1 |
| Materson, BJ | 1 |
| Levenstein, M | 1 |
| Jonas, M | 1 |
| Haim, M | 1 |
| Gottlieb, S | 1 |
| Hod, H | 1 |
| Oei, SG | 1 |
| Oei, SK | 1 |
| Brölmann, HA | 1 |
| Boev, SS | 1 |
| Gillman, MW | 1 |
| Ross-Degnan, D | 1 |
| McLaughlin, TJ | 1 |
| Gao, X | 1 |
| Spiegelman, D | 1 |
| Hertzmark, E | 1 |
| Goldman, L | 1 |
| Soumerai, SB | 1 |
| Taguchi, T | 1 |
| Uchida, W | 1 |
| Takeo, S | 1 |
| Aimond, F | 1 |
| Alvarez, JL | 1 |
| Rauzier, JM | 1 |
| Lorente, P | 1 |
| Vassort, G | 1 |
| Jollis, JG | 1 |
| Simpson, RJ | 1 |
| Chowdhury, MK | 1 |
| Cascio, WE | 1 |
| Crouse, JR | 1 |
| Massing, MW | 1 |
| Smith, SC | 1 |
| Avanzini, F | 1 |
| Tognoni, G | 1 |
| Asanuma, H | 1 |
| Kitakaze, M | 1 |
| Funaya, H | 1 |
| Takashima, S | 1 |
| Minamino, T | 2 |
| Node, K | 1 |
| Sakata, Y | 1 |
| Asakura, M | 1 |
| Sanada, S | 1 |
| Shinozaki, Y | 1 |
| Kuzuya, T | 1 |
| Tada, M | 1 |
| Hori, M | 1 |
| Yamamoto, S | 1 |
| Matsui, K | 1 |
| Sasabe, M | 1 |
| Ohashi, N | 1 |
| Parsons, RW | 1 |
| Hung, J | 1 |
| Hanemaaijer, I | 1 |
| Jbroadhurst, R | 1 |
| Jamrozik, K | 1 |
| Hobbs, MS | 1 |
| Schenk, KE | 1 |
| Ravazzi, PA | 2 |
| Taverna, G | 2 |
| Ivaldi, M | 2 |
| Anfossi, F | 1 |
| Repetto, S | 2 |
| Cozzi, A | 1 |
| Binaghi, G | 2 |
| Johansson, BW | 1 |
| Gunther, SJ | 1 |
| Lown, B | 1 |
| Lotto, A | 2 |
| Foresti, A | 2 |
| Satolli, R | 1 |
| Moglia, F | 1 |
| D'Amore, F | 1 |
| Ferrera, U | 1 |
| Garassini, G | 1 |
| Schena, V | 1 |
| De Ponti, C | 1 |
| Mauri, F | 1 |
| Fiorista, F | 1 |
| Ciliberto, GR | 1 |
| Carù, B | 1 |
| Rovelli, F | 1 |
| Arancio, F | 1 |
| Boscarini, M | 1 |
| Verna, E | 1 |
| Rossi, P | 1 |
| Giordano, A | 1 |
| Tamiz, A | 1 |
| Schiavo, B | 1 |
| Minuco, G | 1 |
| Selwyn, AP | 1 |
| Welman, E | 1 |
| Fox, K | 2 |
| Horlock, P | 1 |
| Pratt, T | 1 |
| Klein, M | 1 |
| Mahlo, KL | 1 |
| Bussmann, WD | 1 |
| Löhner, J | 1 |
| Schöfer, H | 1 |
| Auchampach, JA | 1 |
| Maruyama, M | 1 |
| Pieper, GM | 1 |
| Hansen, JF | 2 |
| Kosminskiĭ, PG | 2 |
| Vaniev, SB | 2 |
| Vasechkin, SS | 2 |
| Lazarev, IA | 1 |
| Gruzdev, AK | 2 |
| Magnitskiĭ, AV | 2 |
| Sidorenko, BA | 2 |
| Nikitin, IuP | 1 |
| Kurilovich, VP | 1 |
| Laor, A | 1 |
| Cohen, A | 1 |
| Hagar, JM | 1 |
| Newman, LG | 1 |
| Sharapov, VI | 1 |
| Grek, OR | 1 |
| Anan'ev, EA | 1 |
| Kolpakov, MA | 1 |
| Rao, MR | 1 |
| Jiang, H | 1 |
| Shui, B | 1 |
| Dupuis, JY | 1 |
| Nathan, HJ | 2 |
| Laganière, S | 2 |
| Zhdanova, SM | 1 |
| Leung, JM | 1 |
| Browner, WS | 1 |
| Dubé, L | 1 |
| Foster, B | 1 |
| McGilveray, I | 1 |
| Harrison, M | 1 |
| Bourke, M | 1 |
| Cattran, C | 1 |
| de LaSalle, G | 1 |
| Robblee, J | 1 |
| Horváth, M | 1 |
| Mezey, Z | 1 |
| Jósfay, A | 1 |
| Nánay, I | 1 |
| Varsányi, M | 1 |
| Geró, S | 1 |
| Podczeck, A | 1 |
| Frohner, K | 1 |
| Steinbach, K | 1 |
| Kowey, P | 1 |
| Grodzicki, T | 1 |
| Ebner, F | 1 |
| Persson, S | 1 |
| Gheorghiade, M | 1 |
| Hellstrom, HR | 1 |
| Khan, RM | 1 |
| Khan, TZ | 1 |
| Sud, P | 1 |
| Haq, G | 1 |
| Zafaruddin, M | 1 |
| Seitelberger, R | 2 |
| Zwölfer, W | 2 |
| Huber, S | 2 |
| Schwarzacher, S | 2 |
| Binder, TM | 2 |
| Peschl, F | 2 |
| Spatt, J | 2 |
| Holzinger, C | 2 |
| Podesser, B | 1 |
| Buxbaum, P | 1 |
| Rogers, WJ | 1 |
| Babb, JD | 1 |
| Baim, DS | 1 |
| Chesebro, JH | 1 |
| Gore, JM | 1 |
| Williams, DO | 1 |
| Frederick, M | 1 |
| Passamani, ER | 1 |
| Morikami, Y | 1 |
| Yasue, H | 1 |
| Yusuf, S | 2 |
| Held, P | 1 |
| Furberg, C | 1 |
| Nathan, H | 1 |
| Burton, JR | 1 |
| Haraphongse, M | 1 |
| Hsu, L | 1 |
| Kappagoda, CT | 1 |
| Rossall, RE | 1 |
| Schlaut, B | 1 |
| Senaratne, MP | 1 |
| Barbaro, G | 1 |
| Murri, G | 1 |
| Profenna, LM | 1 |
| Avella, A | 1 |
| Coraim, F | 1 |
| Weber, H | 1 |
| Cohn, PF | 1 |
| Degré, SG | 1 |
| Fang, ZY | 1 |
| Sobolski, J | 1 |
| Abramowicz, M | 1 |
| Berkenboom, G | 1 |
| Sharaf el-Deane, MS | 1 |
| Parker, BM | 1 |
| Ischinger, T | 1 |
| Coppenrath, K | 1 |
| Antoni, D | 1 |
| Nowak, F | 1 |
| Delius, W | 1 |
| Wang, J | 1 |
| Bekheit, S | 1 |
| Tangella, M | 1 |
| el-Sakr, A | 1 |
| Rasheed, Q | 1 |
| Craelius, W | 1 |
| Sorkin, EM | 1 |
| Clissold, SP | 1 |
| Brogden, RN | 1 |
| Sinitsyn, SP | 1 |
| Wilson, JA | 2 |
| Reynolds, GW | 2 |
| Nelson, GI | 2 |
| Hardman, HF | 1 |
| Blanke, H | 1 |
| Leschke, M | 1 |
| Motz, W | 1 |
| Strauer, BE | 1 |
| Akhras, F | 1 |
| Chambers, J | 1 |
| Jefferies, S | 1 |
| Jackson, G | 1 |
| Hofmann, T | 1 |
| Kasper, W | 3 |
| Geibel, A | 1 |
| Wollschläger, H | 1 |
| Meinertz, T | 3 |
| Brunke, W | 1 |
| Anders, G | 1 |
| Müller, JH | 1 |
| Abet, U | 1 |
| Bodammer, M | 1 |
| Lucchesi, BR | 2 |
| Tamura, Y | 2 |
| Hoff, PT | 1 |
| Bestetti, RB | 1 |
| Pinto, LZ | 1 |
| Finzi, LA | 1 |
| Secches, AL | 1 |
| van Wezel, HB | 1 |
| Mauser, M | 1 |
| Ickrath, O | 1 |
| Hoffmeister, HM | 1 |
| Cheng, TO | 1 |
| Skolnick, AE | 1 |
| Frishman, WH | 1 |
| Brachmann, J | 1 |
| Aidonidis, I | 1 |
| Dembowsky, K | 1 |
| Seller, H | 1 |
| Kuebler, W | 1 |
| An, RH | 1 |
| Fu, SX | 1 |
| Li, YS | 1 |
| Meyer, J | 2 |
| Merx, W | 1 |
| Dörr, R | 1 |
| Erbel, R | 2 |
| von Essen, R | 1 |
| Lambertz, H | 1 |
| Bethge, C | 1 |
| Schmitz, HJ | 1 |
| Bardos, P | 1 |
| Minale, C | 1 |
| Babarskene, RS | 1 |
| Bloznialene, KP | 1 |
| Bluzhaĭte, II | 1 |
| Gaulene, AP | 1 |
| Fleckenstein, A | 1 |
| Nayler, W | 1 |
| Soward, AL | 1 |
| Keegan, J | 1 |
| Cunningham, D | 1 |
| Quyyumi, A | 1 |
| Crean, P | 1 |
| Park, A | 1 |
| Wright, C | 1 |
| Hussain, M | 1 |
| Richmond, A | 1 |
| Shettigar, UR | 1 |
| Loungani, R | 1 |
| Mehta, J | 1 |
| Lopez, LM | 1 |
| Walker, LJ | 2 |
| MacKenzie, G | 2 |
| Wells, DG | 1 |
| Zelcer, J | 1 |
| Treadrae, C | 1 |
| Massari, FM | 1 |
| Bertoni, T | 1 |
| Ambrosini, F | 1 |
| Finzi, A | 1 |
| Valentini, R | 1 |
| Matta, F | 1 |
| Wilcox, RG | 1 |
| Hampton, JR | 1 |
| Banks, DC | 1 |
| Birkhead, JS | 1 |
| Brooksby, IA | 1 |
| Burns-Cox, CJ | 1 |
| Hayes, MJ | 1 |
| Joy, MD | 1 |
| Malcolm, AD | 1 |
| Mather, HG | 1 |
| Vassanelli, C | 1 |
| Menegatti, G | 1 |
| Nidasio, GP | 1 |
| Franceschini, L | 1 |
| Cocco, C | 1 |
| Rizzotti, P | 1 |
| Jiang, YQ | 1 |
| Na, S | 1 |
| Ma, FX | 1 |
| Shi, HQ | 1 |
| Haverkamp, W | 1 |
| Hindricks, G | 1 |
| Shimizu, Y | 1 |
| Tanaka, T | 1 |
| Takayama, Y | 1 |
| Ito, Y | 1 |
| Abe, M | 1 |
| Matsuda, M | 1 |
| Ida, T | 1 |
| Sakakibara, T | 1 |
| Obunai, Y | 1 |
| Lupínek, Z | 1 |
| Lupínková, Z | 1 |
| Janousek, S | 1 |
| Raman, PG | 1 |
| Mishra, VN | 1 |
| Singh, D | 1 |
| Karasawa, A | 1 |
| Kubo, K | 1 |
| Pop, T | 1 |
| Olshausen, KV | 1 |
| Treese, N | 1 |
| Henrichs, KJ | 1 |
| Schuster, CJ | 1 |
| Rupprecht, HJ | 1 |
| Schlürmann, W | 1 |
| Gottlieb, SO | 1 |
| Shapiro, EP | 1 |
| Chandra, NC | 1 |
| Gottlieb, SH | 1 |
| Townsend, SN | 1 |
| Drexler, H | 1 |
| Hümmler, S | 1 |
| Zeiher, A | 1 |
| Kerkkamp, HJ | 2 |
| Viersma, JW | 1 |
| de Beijer, JM | 1 |
| de Feijter, PJ | 1 |
| Cyran, J | 1 |
| Kuthan, P | 1 |
| Remien, P | 1 |
| Fischer, J | 1 |
| Henselmann, L | 1 |
| Leonowicz, K | 1 |
| Niemczuk-Lopaszyńska, E | 1 |
| Deptulski, T | 1 |
| Zelechowska, K | 1 |
| Vatner, SF | 1 |
| Patrick, TA | 1 |
| Knight, DR | 1 |
| Manders, WT | 1 |
| Fallon, JT | 1 |
| Zhuravlev, AK | 1 |
| Murashko, VV | 1 |
| Kamchatnov, PR | 1 |
| Vuori, I | 1 |
| Hämäläinen, H | 1 |
| Pietilä, J | 1 |
| Kallio, V | 1 |
| Iakovlev, SV | 1 |
| Lazutin, VK | 1 |
| Glezer, MG | 1 |
| Chistova, VS | 1 |
| Sergeeva, EV | 1 |
| Umezawa, S | 1 |
| Nogami, A | 1 |
| Taniguchi, K | 1 |
| Takeuchi, J | 1 |
| Fujiwara, H | 1 |
| Amemiya, H | 1 |
| Shiroyama, N | 1 |
| Hiroe, M | 1 |
| Friedmann, J | 1 |
| Reicher, H | 1 |
| Cheung, JY | 1 |
| Bonventre, JV | 1 |
| Malis, CD | 1 |
| Leaf, A | 1 |
| Moss, AJ | 2 |
| Neufeld, HN | 1 |
| Gasser, RN | 1 |
| Dienstl, F | 1 |
| Puschendorf, B | 1 |
| Hauptlorenz, S | 1 |
| Moll, M | 1 |
| Dworzak, E | 1 |
| Kendall, MJ | 2 |
| Horton, RC | 2 |
| Biello, DR | 2 |
| Geltman, EM | 2 |
| Yuan, JN | 1 |
| Wang, LH | 1 |
| Xu, YY | 1 |
| O'Mailia, JJ | 1 |
| Sander, GE | 1 |
| Giles, TD | 1 |
| Nienaber, CA | 1 |
| Spielmann, RP | 1 |
| Aschenberg, W | 1 |
| Fehr, A | 1 |
| Clausen, A | 1 |
| Bleifeld, W | 1 |
| Walley, TJ | 1 |
| Heagerty, AM | 1 |
| Woods, KL | 1 |
| Bing, RF | 1 |
| Pohl, JE | 1 |
| Barnett, DB | 1 |
| Mehta, SR | 1 |
| Malhotra, H | 1 |
| Agarwal, S | 1 |
| Mathur, D | 1 |
| Khandelwal, PD | 1 |
| MacMillan, RM | 1 |
| Cha, SD | 1 |
| Maranhao, V | 1 |
| Myrhed, M | 1 |
| Wiholm, BE | 1 |
| Carosio, G | 1 |
| Guarraggi, F | 1 |
| Sangiacomo, G | 1 |
| Endo, T | 1 |
| Nejima, J | 1 |
| Fujita, S | 1 |
| Kiuchi, K | 1 |
| Iida, N | 1 |
| Kikuchi, K | 1 |
| Hayakawa, H | 1 |
| Okumura, H | 1 |
| Soopyl'd, IuKh | 1 |
| Laane, EIa | 1 |
| Uuskiula, MM | 1 |
| Altraia, EM | 1 |
| Nesto, RW | 1 |
| Phillips, RT | 1 |
| Saenz, CB | 1 |
| Taylor, JL | 1 |
| Soto, B | 1 |
| Nanda, NC | 1 |
| Kirklin, JK | 1 |
| Kudoh, Y | 1 |
| Maxwell, MP | 2 |
| Yoshida, S | 2 |
| Branagan, JP | 1 |
| Walsh, K | 1 |
| Kelly, P | 1 |
| Collins, WC | 1 |
| McCafferty, D | 1 |
| Walsh, MJ | 1 |
| Weinberger, I | 1 |
| Fuchs, J | 1 |
| Rotenberg, Z | 1 |
| Rappaport, M | 1 |
| Stockins, B | 1 |
| Opazo, J | 1 |
| Gamboa, C | 1 |
| Salvatici, R | 1 |
| Lanas, F | 1 |
| Saavedra, J | 1 |
| Curimil, N | 1 |
| Karstegl, P | 1 |
| Reimer, KA | 1 |
| Jennings, RB | 1 |
| Winniford, MD | 1 |
| Willerson, JT | 1 |
| Hillis, LD | 1 |
| Josephson, MA | 1 |
| Loogna, E | 1 |
| Sylvén, C | 1 |
| Groth, T | 1 |
| Mogensen, L | 1 |
| van Rijk, PP | 1 |
| Bom, N | 1 |
| Eisenberg, PR | 1 |
| Lee, RG | 1 |
| Merin, RG | 1 |
| Lowenstein, E | 1 |
| Gelman, S | 1 |
| Sia, ST | 1 |
| MacDonald, PS | 1 |
| Triester, B | 1 |
| Oliver, LE | 1 |
| Horowitz, JD | 1 |
| Goble, AJ | 1 |
| Nakano, T | 1 |
| Konishi, T | 1 |
| Takezawa, H | 1 |
| Hirasawa, K | 1 |
| Shen, WF | 1 |
| Kelly, DT | 1 |
| Roubin, G | 1 |
| Tateda, K | 1 |
| Shibata, J | 1 |
| Ruksin, VV | 1 |
| Sakai, M | 1 |
| Ueda, K | 1 |
| Nakahara, K | 1 |
| Tsuchimochi, H | 1 |
| Mutsushita, S | 1 |
| Kuramoto, K | 1 |
| Murakami, M | 1 |
| Kaur, AH | 1 |
| Singh, M | 1 |
| Singh, J | 1 |
| Jain, K | 1 |
| Fukui, S | 1 |
| Tani, A | 1 |
| Katoh, O | 1 |
| Hamano, Y | 1 |
| Bertazzoni, G | 1 |
| Migliau, G | 1 |
| Pantani, E | 1 |
| De Castro, S | 1 |
| Rosini, A | 1 |
| Crottogini, AJ | 1 |
| Depaoli, JR | 1 |
| Barra, JG | 1 |
| Fischer, EC | 1 |
| Rodríguez Chatruc, M | 1 |
| Pichel, RH | 1 |
| de la Fuente, L | 1 |
| Van Lith, RM | 1 |
| Appleby, DH | 1 |
| Lehmann, M | 1 |
| Hasler, K | 1 |
| Hasenfuss, G | 1 |
| Holubarsch, C | 1 |
| Staiger, A | 1 |
| Keul, J | 1 |
| Curtis, MJ | 1 |
| Johnston, KM | 1 |
| Macleod, BA | 1 |
| Walker, MJ | 1 |
| Pust, B | 1 |
| Obrez, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prognostic Models for People With Stable Coronary Artery Disease[NCT01609465] | 300,000 participants (Anticipated) | Observational | 2010-01-31 | Active, not recruiting | |||
| [NCT00000478] | Phase 3 | 0 participants | Interventional | 1990-11-30 | Completed | ||
| DiME Study: Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Response: A Prospective Randomized and Double-Blinded Non-Inferiority Trial of Safety and Efficacy[NCT01914926] | Phase 4 | 54 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| [NCT00000505] | Phase 3 | 0 participants | Interventional | 1983-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Percent of patient who reached a HR<100bpm within 30 minutes from baseline. (NCT01914926)
Timeframe: 30 minutes
| Intervention | percentage of participants (Number) |
|---|---|
| Metoprolol Study Group | 46.4 |
| Diltiazem Study Group | 95.8 |
46 reviews available for nifedipine and Cardiovascular Stroke
| Article | Year |
|---|---|
Prevention of cardiogenic shock.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Creatine Kinase; Echocardiography; Electrocardiograph | 1980 |
Calcium antagonists and the acutely ischemic heart: experimental effects on ventricular fibrillation and enzyme release.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Calcium Channel Blockers; Humans; L-Lactate Dehydroge | 1983 |
[Unstable angina pectoris and pre-infarct syndrome].
Topics: Angina Pectoris, Variant; Angioplasty, Balloon; Coronary Angiography; Coronary Disease; Coronary Vas | 1983 |
Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.
Topics: Angina Pectoris; Angina Pectoris, Variant; Animals; Arrhythmias, Cardiac; Benzazepines; Calcium; Car | 1980 |
Mechanism of action of calcium-channel-blocking agents.
Topics: Action Potentials; Angina Pectoris; Arrhythmias, Cardiac; Blood Vessels; Calcium; Calcium Channel Bl | 1982 |
[News in cardiology].
Topics: Heart Diseases; Humans; Myocardial Infarction; Nifedipine; Sulfinpyrazone | 1983 |
Nifedipine in acute myocardial infarction.
Topics: Angina Pectoris; Animals; Clinical Enzyme Tests; Clinical Trials as Topic; Creatine Kinase; Dogs; Do | 1984 |
S-T segment elevation and coronary spasm in response to exercise.
Topics: Angina Pectoris; Angina Pectoris, Variant; Constriction, Pathologic; Coronary Angiography; Diltiazem | 1981 |
Pharmacological basis for the therapeutic applications of slow-channel blocking drugs.
Topics: Animals; Atrioventricular Node; Calcium Channel Blockers; Coronary Circulation; Electrophysiology; H | 1982 |
[Advances in cardiovascular diseases in China].
Topics: Catheter Ablation; Humans; Hypertension; Myocardial Infarction; Nifedipine; Urokinase-Type Plasminog | 1993 |
[Calcium antagonists--much noise about nothing?].
Topics: Calcium Channel Blockers; Dose-Response Relationship, Drug; Humans; Hypertension; Myocardial Infarct | 1995 |
Circadian rhythms and the onset of myocardial infarction: clinical implications.
Topics: Blood Pressure; Circadian Rhythm; Humans; Myocardial Infarction; Nifedipine; Randomized Controlled T | 1995 |
[Silent myocardial ischemia. Arguments against treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Atenolol; Bisoprolol; Calcium Channe | 1996 |
1995: the year of the calcium antagonist controversy.
Topics: Calcium Channel Blockers; Humans; Hypertension; Myocardial Infarction; Myocardial Ischemia; Nifedipi | 1996 |
The value of nifedipine in the treatment of hypertension, coronary heart disease and myocardial infarction (post-infarction therapy).
Topics: Adult; Aged; Calcium Channel Blockers; Coronary Disease; Female; Germany; Humans; Hypertension; Male | 1996 |
A comparative review of the adverse effects of calcium antagonists.
Topics: Arrhythmias, Cardiac; Calcium Channel Blockers; Cardiovascular System; Endocrine System Diseases; Ga | 1996 |
Safety of calcium antagonists: dissecting the evidence.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Gastrointestinal Hemorrhage; Humans; Myocardial | 1996 |
Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
Topics: Calcium Channel Blockers; Catecholamines; Cerebrovascular Disorders; Drug Evaluation; Gastrointestin | 1997 |
Calcium channel blockers: an evidence-based review.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diltiazem; Humans; Myocardial In | 1997 |
Drug-induced chest pain and myocardial infarction. Reports to a national centre and review of the literature.
Topics: Adverse Drug Reaction Reporting Systems; Angina Pectoris; Calcium Channel Blockers; Female; Humans; | 1997 |
[Controversy about using calcium antagonists for treatment of coronary disease and hypertension].
Topics: Calcium Channel Blockers; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Hum | 1997 |
Calcium channel antagonists: morbidity and mortality--what's the evidence?
Topics: Administration, Sublingual; Aged; Calcium Channel Blockers; Gastrointestinal Hemorrhage; Humans; Hyp | 1998 |
Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
Topics: Amlodipine; Calcium Channel Blockers; Cause of Death; Cerebrovascular Disorders; Clinical Trials as | 1998 |
Hypotension and coronary events on nifedipine: reassessing nifedipine safety.
Topics: Angina, Unstable; Calcium Channel Blockers; Contraindications; Drug Evaluation; France; Humans; Hype | 1998 |
Clinical aspects of Ca-blocking agents.
Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Calcium; Coronary Disease; Cricetinae; Humans; Hyper | 1978 |
Myocardial infarction. Secondary prevention with nifedipine.
Topics: Female; Heart; Humans; Male; Myocardial Infarction; Nifedipine; Recurrence; Risk Factors | 1991 |
Calcium antagonists in secondary prevention after myocardial infarction.
Topics: Calcium Channel Blockers; Diltiazem; Female; Humans; Male; Meta-Analysis as Topic; Myocardial Infarc | 1991 |
Calcium channel blockers in the management of myocardial infarction patients.
Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Nifedipine; Verapamil | 1991 |
Calcium antagonists and myocardial infarction.
Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Nifedipine; Verapamil | 1991 |
Postinfarction cardiac dilatation. Is it modifiable?
Topics: Animals; Captopril; Cardiomegaly; Humans; Myocardial Contraction; Myocardial Infarction; Nifedipine; | 1990 |
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.
Topics: Absorption; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Blood Platelets; Calcium Channel | 1985 |
Calcium channel blockers in myocardial infarction.
Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Nifedipine; Verapamil | 1989 |
Review of calcium antagonist trials in acute myocardial infarction.
Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Nifedipine; Randomized Controlle | 1989 |
Why Ca2+ antagonists will be most useful before or during early myocardial ischaemia and not after infarction has been established.
Topics: Adrenergic beta-Antagonists; Angina, Unstable; Animals; Calcium Channel Blockers; Coronary Disease; | 1986 |
Nifedipine and metoprolol in suspected unstable angina. Review of other trials.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Humans; My | 1987 |
[Calcium antagonists in acute myocardial infarction].
Topics: Calcium Channel Blockers; Diltiazem; Gallopamil; Hemodynamics; Humans; Myocardial Infarction; Nifedi | 1988 |
Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
Topics: Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Coronary Disease; Diltiazem; Drug Thera | 1988 |
Preventing recurrent myocardial infarction. Use of calcium-channel blockers.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Electrocardiography; Humans; Myocardi | 1988 |
Calcium and ischemic injury.
Topics: Animals; Calcium; Calcium Channel Blockers; Chlorpromazine; Cytosol; Extracellular Space; Homeostasi | 1986 |
New perspectives on the function of coronary artery spasm in acute myocardial infarction: the thromboischemic reentry mechanism. A review of 10 years research on the pathophysiology of AMI.
Topics: Animals; Calcium Channel Blockers; Coronary Vasospasm; Coronary Vessels; Drug Therapy, Combination; | 1986 |
A clinical review of calcium antagonists in acute myocardial infarction.
Topics: Animals; Calcium Channel Blockers; Coronary Circulation; Heart Rate; Humans; Myocardial Infarction; | 1986 |
Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Humans; Myocardial Infarction; Nifedi | 1987 |
Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction.
Topics: Animals; Calcium Channel Blockers; Collateral Circulation; Coronary Circulation; Coronary Disease; D | 1985 |
Calcium antagonists for acute ischemic heart disease.
Topics: Acute Disease; Angina Pectoris, Variant; Angina, Unstable; Calcium Channel Blockers; Coronary Diseas | 1985 |
Use of calcium antagonists in ventricular dysfunction.
Topics: Calcium Channel Blockers; Diltiazem; Heart Diseases; Heart Ventricles; Hemodynamics; Humans; Hyperte | 1985 |
Are calcium antagonists cardioprotective?
Topics: Angina Pectoris; Animals; Blood Viscosity; Calcium Channel Blockers; Clinical Trials as Topic; Coron | 1985 |
91 trials available for nifedipine and Cardiovascular Stroke
| Article | Year |
|---|---|
Importance of sustained and "tight" blood pressure control in patients with high cardiovascular risk.
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Cardio | 2016 |
Prognostic importance of pretreatment and on-treatment blood pressure: Further analysis of the ACTION database and the effect of nifedipine gastrointestinal therapeutic system.
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Cardio | 2016 |
[Effect of calcium antagonists on long-term prognosis of patients with myocardial infarction].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Drug Therapy, Combinatio | 2002 |
The effects of acupuncture in treatment of coronary heart diseases.
Topics: Acupuncture Therapy; Angina Pectoris; Animals; Dogs; Electroacupuncture; Electrocardiography; Female | 2004 |
Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Cohort Studies; Female; Humans; Male; Middle | 2005 |
The development of heart failure in patients with stable angina pectoris.
Topics: Aged; Angina Pectoris; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardi | 2007 |
Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with previous myocardial infarction (JMIC-B substudy).
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Coronary Angiograph | 2007 |
Hemodynamic effects of sublingual nifedipine in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Rate; Hemody | 1984 |
Acute myocardial ischaemia: what information can be expected in the near future from ongoing clinical trials with nifedipine?
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Electrocardiography; Humans; Metoprolol | 1983 |
Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.
Topics: Adult; Age Factors; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Middle Aged; Myocar | 1984 |
Hemodynamic and clinical findings after combined therapy with metoprolol and nifedipine in acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combinatio | 1984 |
Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial.
Topics: Adult; Aged; Clinical Trials as Topic; Creatine Kinase; Electrocardiography; Female; Hemodynamics; H | 1984 |
[Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo].
Topics: Adult; Aged; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Bli | 1984 |
Nifedipine in acute myocardial infarction.
Topics: Angina Pectoris; Animals; Clinical Enzyme Tests; Clinical Trials as Topic; Creatine Kinase; Dogs; Do | 1984 |
[Preliminary note on the use of calcium antagonists in ischemic cardiopathy].
Topics: Adult; Angina Pectoris; Benzazepines; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; | 1984 |
[Therapeutic effectiveness of the transdermal system with nitroglycerin in comparison with nifedipine].
Topics: Administration, Topical; Adult; Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Tes | 1984 |
[Dynamics of critical stenosis in patients with unstable angina pectoris].
Topics: Angina Pectoris; Angina, Unstable; Coronary Angiography; Coronary Circulation; Coronary Disease; Hem | 1984 |
The value of amiodarone for the treatment of unstable angina.
Topics: Adult; Aged; Amiodarone; Angina Pectoris; Angina, Unstable; Benzofurans; Drug Evaluation; Drug Thera | 1983 |
Coronary recanalization in acute myocardial infarction: immediate results and potential risks.
Topics: Adult; Cardiac Catheterization; Clinical Trials as Topic; Coronary Vessels; Fibrinolysis; Fibrinolyt | 1982 |
Clinical course after attempted thrombolysis in myocardial infarction. Results of pilot studies and preliminary data from a randomized trial.
Topics: Clinical Trials as Topic; Coronary Vessels; Coumarins; Exercise Test; Female; Fibrinolysis; Follow-U | 1982 |
The effect of intracoronary thrombolysis with streptokinase on myocardial thallium distribution and left ventricular function assessed by blood-pool scintigraphy.
Topics: Clinical Trials as Topic; Coronary Circulation; Coronary Vessels; Fibrinolysis; Heart; Humans; Myoca | 1982 |
Acute effects of chewable nifedipine on hemodynamic responses to upright exercise in patients with prior myocardial infarction and effort angina.
Topics: Administration, Oral; Adult; Angina Pectoris; Cardiac Catheterization; Cardiac Output; Exercise Test | 1983 |
Hemodynamic effects of calcium ion antagonists after acute myocardial infarction.
Topics: Adult; Aged; Benzazepines; Blood Pressure; Clinical Trials as Topic; Diltiazem; Heart Rate; Humans; | 1980 |
Nifedipine in unstable angina: a double-blind, randomized trial.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Coronary Artery By | 1982 |
[The comparative efficacy of verapamil, nifedipine and propranolol in patients with IHD and an enhanced risk of a fatal outcome].
Topics: Adult; Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Exercise Tolerance; Humans; Ma | 1994 |
Stroke risk after anterior wall acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Topics: Aged; Atrial Fibrillation; Cerebrovascular Disorders; Chronic Disease; Female; Follow-Up Studies; Hu | 1995 |
Twenty-five-year mortality rate decrease in patients in Israel with a first episode of acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial Study Group. Israeli Thrombolytic Survey Group.
Topics: Adult; Age Distribution; Aged; Cohort Studies; Female; Hospital Mortality; Humans; Israel; Male; Mid | 1995 |
Early risk stratification of patients with a first inferior wall acute myocardial infarction. SPRINT Study Group.
Topics: Aged; Aged, 80 and over; Female; Follow-Up Studies; Hospital Mortality; Humans; Israel; Male; Middle | 1995 |
Immediate and long-term prognostic significance of a first anterior versus first inferior wall Q-wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group.
Topics: Aged; Confounding Factors, Epidemiologic; Female; Humans; Logistic Models; Male; Middle Aged; Multiv | 1993 |
Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.
Topics: Aged; Female; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Nifedipine; Odds Ra | 1993 |
[Cardiac protection in heart surgery interventions by preventive drug administration before extracorporeal circulation. Studies with troponin T as a parameter for perioperative myocardial damage].
Topics: Aged; Biomarkers; Cardiopulmonary Bypass; Coronary Artery Bypass; Creatine Kinase; Dose-Response Rel | 1993 |
Nifedipine does not improve survival in AMI patients without heart failure. The SPRINT Study Group.
Topics: Heart Failure; Humans; Myocardial Infarction; Nifedipine; Survival Analysis | 1993 |
Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Atenolol; Calcium Channel Blocker | 1997 |
Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
Topics: Aged; Angina Pectoris; Calcium Channel Blockers; Diltiazem; Female; Humans; Male; Middle Aged; Multi | 1997 |
Calcium channel blockers: an evidence-based review.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diltiazem; Humans; Myocardial In | 1997 |
Relationship between calcium channel antagonists and nocturnal hypotension and autonomic imbalance in patients with a previous myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Autonomic Nervous System; Blood Pressure; Blood Pressure Monitoring, A | 1998 |
Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Topics: Adult; Age Factors; Aged; Calcium Channel Blockers; Female; Follow-Up Studies; Humans; Male; Middle | 1998 |
Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction.
Topics: Aged; Calcium Channel Blockers; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; | 1998 |
Prognosis of patients with a first non-Q-wave myocardial infarction before and in the reperfusion era. SPRINT and the Israeli Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israeli Nifedipine Trial.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Cause of Death; Cohort Studies; Confidence Intervals; C | 1998 |
Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group.
Topics: Calcium Channel Blockers; Cause of Death; Diltiazem; Female; Humans; Male; Middle Aged; Myocardial I | 1999 |
[Effectiveness of nifedipine on exercise tolerance in patients with angina pectoris. Comparison with a nitroderivative and a beta-blocking agent].
Topics: Adolescent; Adult; Angina Pectoris; Exercise Test; Heart; Humans; Isosorbide Dinitrate; Middle Aged; | 1977 |
Secondary prevention with calcium antagonists after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Diltiazem; Female; Humans; Male; Middle Aged; Myocardial I | 1992 |
[Antianginal activity of cardil and cordafen in patients with non-Q wave myocardial infarction].
Topics: Aged; Diltiazem; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infa | 1992 |
Analysis of premature ventricular counts in long term ECG following myocardial infarction.
Topics: Cardiac Complexes, Premature; Electrocardiography, Ambulatory; Humans; Israel; Likelihood Functions; | 1992 |
Intravenous nifedipine for prevention of myocardial ischaemia after coronary revascularization.
Topics: Blood Pressure; Coronary Artery Bypass; Creatine Kinase; Electrocardiography; Electrocardiography, A | 1992 |
[Calcium antagonists. The prevention of a recurrent myocardial infarct and sudden death].
Topics: Calcium Channel Blockers; Death, Sudden, Cardiac; Drug Therapy, Combination; Electrocardiography, Am | 1992 |
Amlodipine in post-infarction angina.
Topics: Amlodipine; Angina Pectoris; Calcium Channel Blockers; Circadian Rhythm; Female; Humans; Male; Middl | 1992 |
Intravenous nifedipine to treat hypertension after coronary artery revascularization surgery. A comparison with sodium nitroprusside.
Topics: Blood Pressure; Coronary Artery Bypass; Coronary Disease; Creatine Kinase; Electrocardiography, Ambu | 1992 |
Myocardial infarction. Secondary prevention with nifedipine.
Topics: Female; Heart; Humans; Male; Myocardial Infarction; Nifedipine; Recurrence; Risk Factors | 1991 |
Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting.
Topics: Coronary Artery Bypass; Coronary Disease; Creatine Kinase; Electrocardiography; Electrocardiography, | 1991 |
Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators.
Topics: Aged; Aspirin; Coronary Angiography; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Co | 1991 |
Efficacy of slow-release nifedipine on myocardial ischemic episodes in variant angina pectoris.
Topics: Aged; Aged, 80 and over; Angina Pectoris, Variant; Circadian Rhythm; Coronary Disease; Delayed-Actio | 1991 |
Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.
Topics: Angina, Unstable; Calcium Channel Blockers; Denmark; Humans; Myocardial Infarction; Nicardipine; Nif | 1991 |
Infusion of nifedipine after coronary artery bypass grafting decreases the incidence of early postoperative myocardial ischemia.
Topics: Blood Pressure; Cardiac Output; Coronary Artery Bypass; Coronary Disease; Creatine Kinase; Electroca | 1990 |
[The effect of intravenous nifedipine administration on coronary occlusion during coronary angioplasty on ischemia tolerance and collateral function].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Blood Pressure; Clinical Trials as To | 1990 |
Prognosis of acute myocardial infarction complicated by primary ventricular fibrillation. Principal Investigators of the SPRINT Study.
Topics: Aged; Female; Humans; Incidence; Israel; Male; Middle Aged; Myocardial Infarction; Nifedipine; Progn | 1990 |
Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Diltiazem; Heart Rate; Humans; Male; Metoprol | 1990 |
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.
Topics: Absorption; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Blood Platelets; Calcium Channel | 1985 |
Nifedipine and metoprolol in unstable angina: findings from the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT).
Topics: Aged; Angina Pectoris; Angina, Unstable; Double-Blind Method; Drug Therapy, Combination; Electrocard | 1987 |
A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; E | 1989 |
[The acute hemodynamic effects of the new vasodilating beta blocker carvedilol in comparison with combined administration of nifedipine and propranolol in patients with coronary heart disease].
Topics: Carbazoles; Carvedilol; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Female; H | 1989 |
[Nifedipine in secondary prevention after myocardial infarction. SPRINT Study Group].
Topics: Clinical Trials as Topic; Coronary Care Units; Double-Blind Method; Humans; Israel; Multicenter Stud | 1989 |
Review of calcium antagonist trials in acute myocardial infarction.
Topics: Calcium Channel Blockers; Diltiazem; Humans; Myocardial Infarction; Nifedipine; Randomized Controlle | 1989 |
Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of The Holland Interuniversity Nifedipine/Meto
Topics: Aged; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Coronary Care Units; Double-Blind | 1986 |
Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT).
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Coro | 1987 |
Secondary prevention reinfarction Israeli nifedipine trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. The Israeli Sprint Study Group.
Topics: Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nifedipine; Plac | 1988 |
Circadian variation of total ischaemic burden and its alteration with anti-anginal agents.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Circadian Rhythm; Clinical Trials as Topic; Coronary Disease | 1988 |
Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Calcium Channel Blockers; He | 1988 |
Effect of nifedipine on arrhythmias in the acute phase of myocardial infarction.
Topics: Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Electrocardiograph | 1988 |
Trial of early nifedipine in acute myocardial infarction: the Trent study.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle | 1986 |
Preventing recurrent myocardial infarction. Use of calcium-channel blockers.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Electrocardiography; Humans; Myocardi | 1988 |
Combination of calcium channel blocker and thrombolytic therapy in acute myocardial infarction.
Topics: Adult; Aged; Calcium Channel Blockers; Capsules; Clinical Trials as Topic; Coronary Circulation; Dou | 1988 |
Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction.
Topics: Aged; Clinical Trials as Topic; Creatine Kinase; Double-Blind Method; Female; Humans; Male; Middle A | 1988 |
Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart Ventricles | 1988 |
[Hemodynamic effect of intravenous diltiazem and nifedipine in acute myocardial infarct. A randomized study].
Topics: Adult; Aged; Clinical Trials as Topic; Diltiazem; Female; Hemodynamics; Humans; Injections, Intraven | 1987 |
Nifedipine and metoprolol in suspected unstable angina. Treatment, observations, and outcome events.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Double-Blind Method; Drug | 1987 |
[Calcium antagonists in acute myocardial infarct? Long-term nifedipine infusion in pre-infarct angina and acute myocardial infarct].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Creatine Kinase; Female; Hemodynamics; Human | 1987 |
[Evaluation of the preparation Cordafen (Polfa) in the treatment of angina pectoris in patients after myocardial infarction].
Topics: Adult; Angina Pectoris; Clinical Trials as Topic; Humans; Male; Middle Aged; Myocardial Infarction; | 1987 |
Assessment of exercise tolerance of cardiac patients by bicycle, treadmill and treadmill plus isometric exercise with and without nifedipine.
Topics: Aged; Angina Pectoris; Blood Pressure; Exercise Test; Heart Rate; Humans; Isometric Contraction; Mal | 1987 |
Two cases of sudden death documented by Holter monitor during Secondary Prevention Reinfarction Nifedipine Trial (SPRINT).
Topics: Aged; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Electrocardiography; Female; Fol | 1986 |
Current status of calcium channel blocking drugs after myocardial infarction.
Topics: Calcium Channel Blockers; Canada; Clinical Trials as Topic; Denmark; Diltiazem; Humans; Myocardial I | 1986 |
Calcium antagonists in secondary prevention after acute myocardial infarction: the Secondary Prevention Reinfarction Nifedipine Trial (SPRINT).
Topics: Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Myocardial Infarction; Nifedipi | 1986 |
Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Humans; Myocardial Infarction; Nifedi | 1987 |
Enhancement of metabolism of jeopardized myocardium by nifedipine.
Topics: Blood Pressure; Carbon Radioisotopes; Clinical Trials as Topic; Double-Blind Method; Female; Heart R | 1987 |
Effect of early treatment with nifedipine in suspected acute myocardial infarction.
Topics: Acute Disease; Coronary Disease; Creatine Kinase; Female; Humans; Male; Middle Aged; Myocardial Infa | 1986 |
The acute effect of sublingual nifedipine and isosorbide dinitrate on plasma viscosity in patients with acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Blood Sedimentation; Blood Viscosity; Female; Heart Rate; Hematocrit; H | 1986 |
Are calcium antagonists cardioprotective?
Topics: Angina Pectoris; Animals; Blood Viscosity; Calcium Channel Blockers; Clinical Trials as Topic; Coron | 1985 |
Complexity of enzyme release during acute myocardial infarction in a controlled study with early nifedipine treatment.
Topics: Aged; Clinical Trials as Topic; Creatine Kinase; Double-Blind Method; Humans; Isoenzymes; Kinetics; | 1985 |
Left ventricular performance in unstable angina: assessment with radionuclide techniques.
Topics: Angina Pectoris; Angina, Unstable; Clinical Trials as Topic; Coronary Angiography; Coronary Disease; | 1985 |
Chest pain after nontransmural infarction: the absence of remediable coronary vasospasm.
Topics: Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Vasospasm; Creatine Kinase; Double-Blind M | 1985 |
Effect of food ingestion on nifedipine absorption and haemodynamic response.
Topics: Blood Pressure; Food; Heart Rate; Hemodynamics; Humans; Intestinal Absorption; Kinetics; Male; Middl | 1985 |
206 other studies available for nifedipine and Cardiovascular Stroke
| Article | Year |
|---|---|
Comparative efficacy of generic nifedipine versus brand-name amlodipine for hypertension management in Taiwan.
Topics: Amlodipine; Calcium Channel Blockers; Drugs, Generic; Heart Failure; Humans; Hypertension; Ischemic | 2022 |
The Significance of Recognizing Myocardial Bridge in the Coronary Spasm Diagnosis in Myocardial Infarction with Nonobstructive Coronary Arteries.
Topics: Calcium Channel Blockers; Coronary Angiography; Coronary Vasospasm; Coronary Vessels; Humans; Male; | 2020 |
Added value of sending photograph in diagnosing a medical disease declared at sea: experience of the French Tele-Medical Assistance Service.
Topics: Abscess; Adult; Electrocardiography; Female; Herpes Zoster; Humans; Internet; Male; Middle Aged; Myo | 2017 |
Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study.
Topics: Acute Coronary Syndrome; Aged; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Canada; Cohort | 2008 |
Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experience.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Angiography; Cross-Cultural Comparis | 2010 |
Barnidipine intoxication causing acute myocardial infarction.
Topics: Adult; Calcium Channel Blockers; Coronary Angiography; Electrocardiography; Female; Humans; Myocardi | 2010 |
Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiograp | 2004 |
[Effects of Ca2+ antagonist on cardiomyocytic apoptosis after experimental myocardial infarction].
Topics: Animals; Apoptosis; Calcium Channel Blockers; Disease Models, Animal; fas Receptor; Immunohistochemi | 2004 |
Efficacy of calcium channel blocker in the secondary prevention of myocardial infarction--retrospective analysis of the 10-year prognosis or coronary thrombolysis-treated patients.
Topics: Aged; Calcium Channel Blockers; Coronary Thrombosis; Female; Fibrinolytic Agents; Follow-Up Studies; | 2004 |
Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial.
Topics: Adrenergic beta-Antagonists; Antibiotic Prophylaxis; Benzopyrans; Ethanolamines; Heart Failure; Huma | 2004 |
Calcium antagonists for secondary prevention of myocardial infarction: is there a need to shift from short-acting to long-acting types?
Topics: Amlodipine; Calcium; Calcium Channel Blockers; Female; Humans; Male; Middle Aged; Myocardial Infarct | 2005 |
Safety of calcium antagonists: more ACTION.
Topics: Angina, Unstable; Calcium Channel Blockers; Cardiovascular Diseases; Cohort Studies; Humans; Meta-An | 2005 |
Prognostic significance of electrocardiographic findings in angina at rest. Therapeutic implications.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angina Pectoris; Coronary Angiography; Electro | 1981 |
Nifedipine and beta-blockade as a cause of cardiac failure.
Topics: Adrenergic beta-Antagonists; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Nifedi | 1982 |
[Nifedipine in the therapy of myocardial infarct in patients over 70].
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Digitalis Glycosides; Female; Heart Block | 1982 |
Efficacy of nifedipine therapy for refractory angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; | 1982 |
Pharmacological agents to aid the clinician in combating myocardial ischaemia.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arachidonic Acid; Arachidonic Acids; C | 1983 |
Adjunctive nifedipine therapy in high-risk, medically refractory, unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Angina, Unstable; Blood Pressure; Calcium | 1983 |
[Behavior of ventricular ectopia in the acute phase of infarction with and without nifedipine (Adalat)].
Topics: Acute Disease; Aged; Cardiac Complexes, Premature; Female; Heart Ventricles; Humans; Male; Myocardia | 1983 |
Coronary artery spasm at the site of angioplasty in the first 2 months after successful percutaneous transluminal coronary angioplasty.
Topics: Adult; Angina Pectoris; Angioplasty, Balloon; Coronary Vasospasm; Humans; Male; Middle Aged; Myocard | 1983 |
[Effect of a combined use of propranolol and nifedipine on experimental myocardial infarct size].
Topics: Animals; Dogs; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Hemodynamics; Male; | 1984 |
Effects of nifedipine on triggered activity in 1-day-old myocardial infarction in dogs.
Topics: Action Potentials; Animals; Depression, Chemical; Dogs; Electric Stimulation; Heart Conduction Syste | 1984 |
Development of immune complex nephritis during treatment with the calcium channel-blocking agent nifedipine.
Topics: Antigen-Antibody Complex; Fluorescent Antibody Technique; Glomerulonephritis; Humans; Kidney; Kidney | 1984 |
Nifedipine therapy for coronary vasospasm.
Topics: Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Coronary Vasospasm; Female; Humans; Mal | 1983 |
Acute myocardial infarction in a thirty-six year old postpartum female.
Topics: Adult; Aspirin; Digoxin; Electrocardiography; Ergonovine; Female; Heart Aneurysm; Humans; Isosorbide | 1984 |
Evaluation of the effect of nifedipine in men after myocardial infarction.
Topics: Adult; Cardiac Catheterization; Cardiac Output; Exercise Test; Heart Failure; Hemodynamics; Humans; | 1984 |
[Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
Topics: Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Circulation; Dogs; Electrocardio | 1984 |
Elimination of unstable angina by diltiazem under temporary pacing.
Topics: Aged; Angina Pectoris; Angina, Unstable; Benzazepines; Cardiac Pacing, Artificial; Combined Modality | 1984 |
[Myocardial infarction after the first dose of nifedipine].
Topics: Adult; Aged; Angina Pectoris; Humans; Male; Myocardial Infarction; Nifedipine | 1984 |
Myocardial infarct size limitation. Principles, problems and possibilities.
Topics: Allopurinol; Animals; Coronary Circulation; Dogs; Flurbiprofen; Humans; Metoprolol; Myocardial Infar | 1984 |
Haemodynamic effects of nicardipine in acute myocardial infarction.
Topics: Blood Pressure; Calcium Channel Blockers; Cardiac Output; Dose-Response Relationship, Drug; Heart Ra | 1984 |
[Use of beta-blockers and a calcium antagonist in angina pectoris during the period of postinfarct rehabilitation].
Topics: Angina Pectoris; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Myocardial Infarction; | 1984 |
Natural history of pure coronary artery spasm in patients treated medically.
Topics: Adult; Aged; Coronary Artery Bypass; Coronary Vasospasm; Electrocardiography; Ergonovine; Female; Fo | 1983 |
Gingival hyperplasia caused by nifedipine--a preliminary report.
Topics: Aged; Coronary Artery Bypass; Female; Gingiva; Gingival Hyperplasia; Humans; Hypertension; Male; Mid | 1984 |
[Effects of nicardipine hydrochloride on hemodynamics and regional myocardial functions in experimental coronary ischemia].
Topics: Animals; Calcium Channel Blockers; Dogs; Hemodynamics; Myocardial Contraction; Myocardial Infarction | 1983 |
Protection of the ischemic myocardium with calcium antagonistic drugs.
Topics: Angiocardiography; Animals; Calcium Channel Blockers; Coronary Disease; Dogs; Isoenzymes; L-Lactate | 1983 |
The beneficial effect of nicardipine compared with nifedipine and verapamil in limiting myocardial infarct size in baboons.
Topics: Animals; Calcium Channel Blockers; Female; Hemodynamics; Lidocaine; Male; Myocardial Infarction; Nic | 1983 |
Calcium channel blocking agents. Council on scientific affairs.
Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Asthma; Calcium Channel Blockers; Cardiomyopathy, Hy | 1983 |
The beneficial effect of nicardipine on the healing of myocardial infarcts in dogs.
Topics: Animals; Blood Pressure; Dogs; Hemodynamics; Male; Myocardial Infarction; Myocardium; Nicardipine; N | 1983 |
Protective effect of early and late treatment with nifedipine during myocardial infarction in the conscious dog.
Topics: Animals; Blood Pressure; Coronary Circulation; Dogs; Heart Rate; Myocardial Infarction; Myocardium; | 1984 |
Variant angina in siblings with mild coronary artery disease.
Topics: Adult; Angina Pectoris, Variant; Coronary Disease; Electrocardiography; Humans; Male; Myocardial Inf | 1984 |
Nifedipine in hypertension and heart failure.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heart F | 1984 |
Failure of nifedipine and reperfusion to reduce infarct size relative to region at risk as measured by NADH fluorophotography.
Topics: Animals; Fluorescence; Myocardial Infarction; NAD; Nifedipine; Perfusion; Photography; Rabbits | 1984 |
Effect of atenolol, nifedipine & oxyfedrine on experimental myocardial infarct size in rhesus monkeys.
Topics: Animals; Atenolol; Blood Pressure; Heart Rate; Macaca mulatta; Myocardial Infarction; Nifedipine; Ox | 1984 |
Adverse interaction between nifedipine and beta-blockade.
Topics: Drug Interactions; Humans; Hypotension; Male; Middle Aged; Myocardial Infarction; Nifedipine; Propra | 1981 |
Effects of antiplatelet and calcium antagonist drugs on infarct size in rats.
Topics: Acute Disease; Animals; Aspirin; Blood Platelets; Calcium; Creatine Kinase; Isoproterenol; Lysine; M | 1980 |
[Angina at rest. Clinical, electrocardiographic and angiographic observations in 107 patients].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Angiography; Coronary Artery Bypass; Co | 1980 |
Nifedipine and beta-blockade as a cause of cardiac failure.
Topics: Atenolol; Drug Therapy, Combination; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction | 1982 |
Hemodynamic effects of concomitant nitroglycerin ointment and nifedipine treatment in acute myocardial infarction.
Topics: Aged; Blood Pressure; Cardiac Output; Drug Therapy, Combination; Hemodynamics; Humans; Middle Aged; | 1982 |
Calcium channel blockers.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem | 1983 |
Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
Topics: Animals; Benzazepines; Calcium Channel Blockers; Cardiac Pacing, Artificial; Coronary Circulation; D | 1983 |
The protective effects of nifedipine in the isolated cat heart.
Topics: Animals; Cathepsins; Cats; Coronary Circulation; Coronary Disease; Creatine Kinase; Extracorporeal C | 1983 |
Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Cardiac Catheterization; Coronary Angiograph | 1981 |
The effects of nifedipine on myocardial blood flow and contraction during ischemia in the dog.
Topics: Animals; Coronary Circulation; Dogs; Hemodynamics; Myocardial Contraction; Myocardial Infarction; Ni | 1982 |
Failure of nifedipine therapy to reduce myocardial infarct size in the baboon.
Topics: Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dru | 1982 |
Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction.
Topics: Angina Pectoris; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Diltiazem; Humans; Myocard | 1982 |
Clinical characteristics of patients with variant angina complicated by myocardial infarction or death within 1 month.
Topics: Adult; Angina Pectoris, Variant; Coronary Disease; Coronary Vasospasm; Death, Sudden; Diltiazem; Ele | 1982 |
Acute hemodynamic effects of nifedipine in patients with ischemic heart disease.
Topics: Adult; Aged; Angina Pectoris; Cardiac Pacing, Artificial; Coronary Disease; Female; Hemodynamics; Hu | 1982 |
Nifedipine therapy for recurrent ischemic pain following myocardial infarction.
Topics: Aged; Angina Pectoris; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nifedipine; Pyridin | 1982 |
[The effect of nifedipine as hypotensive agent in patients with ischemic cardiopathy (author's transl)].
Topics: Aged; Antihypertensive Agents; Blood Pressure; Coronary Disease; Female; Hemodynamics; Humans; Hyper | 1982 |
Inpatient treatment of unstable angina: clinical perspective and sequential management.
Topics: Angina Pectoris; Angina Pectoris, Variant; Calcium Channel Blockers; Coronary Disease; Female; Hospi | 1982 |
[The effect of nifedipine on left ventricular function in patients with ischemic heart disease].
Topics: Aged; Female; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nife | 1982 |
Experience with intracoronary streptokinase in 36 patients with acute evolving myocardial infarction.
Topics: Adult; Aged; Aspirin; Coronary Circulation; Coronary Vessels; Female; Fibrinolysis; Humans; Male; Mi | 1982 |
Nifedipine and acute myocardial infarction.
Topics: Acute Disease; Adult; Animals; Coronary Circulation; Dogs; Hemodynamics; Humans; Male; Middle Aged; | 1981 |
Nifedipine--a new calcium antagonist in experimental myocardial necrosis.
Topics: Animals; Calcium; Male; Myocardial Infarction; Myocardium; Necrosis; Nifedipine; Propranolol; Pyridi | 1981 |
Calcium antagonists.
Topics: Angina Pectoris; Calcium Channel Blockers; Cell Membrane; Diltiazem; Heart; Humans; Hypertension; Mu | 1980 |
Reduction of myocardial infarct size by the calcium antagonist fr 7534.
Topics: Animals; Blood Pressure; Collateral Circulation; Coronary Circulation; Dogs; Heart Rate; Myocardial | 1981 |
Calcium antagonists prevent early post-infarction ventricular fibrillation.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Hemodynamics; Male; Myocardial Infarction; | 1981 |
Slow-channel calcium blockers in heart failure: a plea for cautious optimism.
Topics: Calcium Channel Blockers; Heart Failure; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nifedi | 1981 |
Comparison of acute haemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Female; Heart Failure; Heart Rate; Hemodynamics; Humans | 1981 |
[The effects of physical training and nifedipine on patients recovering from acute myocardial infarction (author's transl)].
Topics: Adult; Disability Evaluation; Exercise Test; Exercise Therapy; Humans; Male; Middle Aged; Myocardial | 1981 |
[Hemodynamic monitoring of the effects of sublingual nifedipine in acute myocardial infarct: observations and findings in 20 cases].
Topics: Acute Disease; Female; Hemodynamics; Humans; Male; Myocardial Infarction; Nifedipine; Pyridines | 1981 |
[Effect of nifedipine on experimental myocardial infarct induced by isoproterenol].
Topics: Animals; Isoproterenol; Myocardial Infarction; Nifedipine; Pyridines; Rats; Rats, Inbred Strains | 1981 |
Treatment of angina at rest with nifedipine: a short-term controlled study.
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Female; Follow-Up Studies; Hemo | 1980 |
Hemodynamic effects of a single oral dose of nifedipine following acute myocardial infarction.
Topics: Administration, Oral; Adult; Aged; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contr | 1980 |
[Nifedipine in acute myocardial infarction (author's transl)].
Topics: Aged; Blood Pressure; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Nifedipi | 1980 |
[Reduction of experimental acute myocardial infarction using nifedipine].
Topics: Animals; Blood Pressure; Dogs; Electrocardiography; Female; Heart Rate; Male; Myocardial Contraction | 1980 |
Elevated plasma atrial natriuretic peptide concentrations in hypertensive patients with acute myocardial infarction.
Topics: Acebutolol; Adult; Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output, Low; Creatine Ki | 1995 |
Safety of thrombolysis during menstruation.
Topics: Female; Humans; Menstruation; Myocardial Infarction; Nifedipine; Nitrates; Thrombolytic Therapy | 1994 |
[Image analysis of effects of 4 drugs on coronary occlusion and myocardial reperfusion injury].
Topics: Animals; Female; Image Processing, Computer-Assisted; Male; Myocardial Infarction; Myocardial Reperf | 1993 |
[Reproducibility of heart rate variability measurements in repeated 24-hour long-term ECG registration].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diltiazem; Electrocardiography, Ambulatory; F | 1993 |
Myocardial infarction in the third trimester of pregnancy secondary to an aortic valve thrombus.
Topics: Adult; Aortic Valve; Female; Heart Valve Prosthesis; Heparin; Humans; Myocardial Infarction; Nifedip | 1993 |
[Long-term treatment with calcium antagonists: advantageous effects and risks].
Topics: Calcium Channel Blockers; Controlled Clinical Trials as Topic; Humans; Hypertension; Myocardial Infa | 1995 |
Acute myocardial infarction in a healthy mother using bromocriptine for milk suppression.
Topics: Adult; Bromocriptine; Coronary Vasospasm; Dose-Response Relationship, Drug; Female; Humans; Lactatio | 1996 |
FDA gives calcium channel blockers clean bill of health but warns of short-acting nifedipine hazards.
Topics: Calcium Channel Blockers; Humans; Myocardial Infarction; Nifedipine; Risk; United States; United Sta | 1996 |
The use of short acting calcium channel blockers.
Topics: Calcium Channel Blockers; Humans; Hypertension; Myocardial Infarction; Nifedipine | 1996 |
Nifedipine study.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Cause of Death; Coronary Disease; Humans; Hyperte | 1996 |
Nifedipine trials.
Topics: Antihypertensive Agents; Calcium Channel Blockers; Dose-Response Relationship, Drug; Humans; Hyperte | 1996 |
The effect of nifedipine on ventriculoarterial coupling in old myocardial infarction.
Topics: Aged; Arteries; Blood Pressure; Female; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; M | 1996 |
[Calcium antagonists: safe or unsafe?].
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Humans; Hypertension; Meta-Analysis as Topic; My | 1996 |
Calcium channel blockers in the dock: innocent or guilty?
Topics: Calcium Channel Blockers; Case-Control Studies; Clinical Trials as Topic; Humans; Meta-Analysis as T | 1996 |
Acute myocardial infarction and myocardial bridging: a case report.
Topics: Anistreplase; Atenolol; Coronary Angiography; Coronary Vessel Anomalies; Electrocardiography; Follow | 1996 |
Calcium channel blocker debate: true lies?
Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Hypertension; Myocardial Contraction; Myocardial | 1996 |
Silent myocardial ischemia: some good news.
Topics: Adrenergic beta-Antagonists; Atenolol; Calcium Channel Blockers; Combined Modality Therapy; Coronary | 1997 |
[Early exercise test in patients with myocardial infarction after nifedipine administration of prolonged duration].
Topics: Adult; Aged; Drug Administration Schedule; Echocardiography; Electrocardiography; Exercise Test; Hea | 1996 |
The calcium channel blocker controversy in 1997.
Topics: Calcium Channel Blockers; Cardiac Output, Low; Case-Control Studies; Clinical Trials as Topic; Human | 1997 |
Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Calcium Channel Blockers; Cohort Studies; Diltiazem; Femal | 1998 |
Use of calcium antagonists in post-myocardial infarction patients.
Topics: Calcium Channel Blockers; Case-Control Studies; Humans; Myocardial Infarction; Nifedipine; Verapamil | 1998 |
[Diagnostic and therapeutic procedures by doctors for patients in a hypertensive crisis. An inquiry in 56 internal medicine clinics].
Topics: Acute Disease; Administration, Sublingual; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists | 1998 |
Nifedipine after acute myocardial infarction--sola dosis facit venenum: only the dose determines the harm.
Topics: Calcium Channel Blockers; Humans; Myocardial Infarction; Nifedipine; Recurrence; Risk Assessment | 1998 |
Myocardial infarction during nifedipine therapy for preterm labor.
Topics: Adult; Calcium Channel Blockers; Female; Humans; Myocardial Infarction; Nifedipine; Obstetric Labor, | 1999 |
[Effects of fenigidin treatment regimen on the state of peripheral hemodynamics of patients with stable effort angina pectoris and postinfarction cardiosclerosis].
Topics: Angina Pectoris; Arm; Blood Pressure; Calcium Channel Blockers; Coronary Artery Disease; Female; Hem | 1998 |
Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
Topics: Aged; Calcium Channel Blockers; Dihydropyridines; Diltiazem; Female; Humans; Male; Myocardial Infarc | 1999 |
Sustained-release nifedipine: new indication. Angina: safer drugs are available.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Delayed-Ac | 1998 |
Reduction by ATP-sensitive potassium channel opener, YM934, of experimental myocardial infarct size in anesthetized dogs.
Topics: Animals; Benzoxazines; Calcium Channel Blockers; Coronary Vessels; Cyclic N-Oxides; Dogs; Drug Evalu | 1999 |
Ionic basis of ventricular arrhythmias in remodeled rat heart during long-term myocardial infarction.
Topics: Action Potentials; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animal | 1999 |
Calcium channel blockers and mortality in elderly patients with myocardial infarction.
Topics: Aged; Aged, 80 and over; Amlodipine; Bepridil; Calcium Channel Blockers; Diltiazem; Female; Humans; | 1999 |
INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases | 2000 |
Nifedipine limits infarct size via NO-dependent mechanisms in dogs.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Dogs; Endothelium; Enzyme I | 2001 |
Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats.
Topics: Administration, Oral; Angina Pectoris; Animals; Azocines; Coronary Disease; Electrocardiography; Iso | 2002 |
Prior calcium channel blockade and short-term survival following acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Australia; Calcium Channel Blockers; Diltiazem; Drug Interactions; Fema | 2001 |
[Use of nifedipine and nitroglycerin during exercise therapy in patients with myocardial infarct. Clinical and hemodynamic studies].
Topics: Angina Pectoris; Blood Pressure; Cardiac Complexes, Premature; Cardiac Output; Digoxin; Exercise The | 1978 |
[Individual therapy of coronary disease].
Topics: Coronary Disease; Edema; Humans; Hypertension; Leg; Myocardial Infarction; Nifedipine; Pyridines | 1979 |
[Evaluation of the action of nifedipine on the ischemic myocardium using ergometric and pharmacological tests].
Topics: Adult; Aged; Dopamine; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial In | 1978 |
[Nifedipine in the treatment of hypertensive crises in acute myocardial infarct].
Topics: Humans; Hypertension; Myocardial Infarction; Nifedipine; Pyridines | 1978 |
Nifedipine therapy for Prinzmetal's angina.
Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Coronary Disease; Humans; Male; Myocardial Infarct | 1978 |
Symposium on nifedipine and calcium flux inhibition in the treatment of coronary arterial spasm and myocardial ischemia. Introduction.
Topics: Adult; Angina Pectoris; Calcium; Cardiomyopathies; Coronary Disease; Electrocardiography; Humans; Ma | 1979 |
[Hemodynamic effects of the calcium antagonist, nifedipine, in acute myocardial infarct].
Topics: Acute Disease; Hemodynamics; Humans; Myocardial Infarction; Nifedipine; Pyridines | 1978 |
[Clinical observations on patients with myocardial and coronary sclerosis, myocardial ischemia with anginal attacks and myocardial infarct treated with nifedipine].
Topics: Adult; Aged; Angina Pectoris; Cardiomyopathies; Coronary Disease; Humans; Middle Aged; Myocardial In | 1978 |
[Changes in left ventricular dynamics caused by calcium antagonists].
Topics: Calcium; Coronary Disease; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; | 1978 |
[Calcium inhibitors in the early rehabilitation of patients with myocardial infarct].
Topics: Calcium; Exercise Test; Heart; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nifed | 1978 |
The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs.
Topics: Animals; Blood Pressure; Coronary Circulation; Creatine Kinase; Dogs; Dose-Response Relationship, Dr | 1979 |
[The arresting of cardiac pain with nifedipine (Adalat) in acute myocardial infarct].
Topics: Aged; Angina Pectoris; Humans; Myocardial Infarction; Nifedipine; Pyridines | 1976 |
[Effect of isosorbide dinitrate on fresh myocardial infarct as compared with nifedipine (Bay a 1040)].
Topics: Drug Evaluation; Hemodynamics; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nifedipine; Pyri | 1975 |
Cardioprotective effects of nicorandil.
Topics: Animals; Benzopyrans; Coronary Circulation; Dihydropyridines; Dogs; Female; Heart; In Vitro Techniqu | 1992 |
[Heart failure in acute myocardial infarction: comparing infusions of nifedipine and nitroglycerin].
Topics: Adult; Aged; Aged, 80 and over; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; | 1992 |
Effects of amlodipine on myocardial infarction, infarct expansion, and ventricular geometry in the rat.
Topics: Amlodipine; Analysis of Variance; Animals; Calcium Channel Blockers; Female; Heart; Heart Ventricles | 1992 |
[Pharmacokinetics of antipyrine, nifedipine and diazepam in experimental myocardial infarct].
Topics: Animals; Antipyrine; Cytochrome P-450 Enzyme System; Diazepam; Hydroxylation; Male; Microsomes, Live | 1992 |
[Effects of m-nifedipine on experimental myocardial metabolism and infarct size in rabbits].
Topics: Animals; Dose-Response Relationship, Drug; Isomerism; Lactates; Male; Myocardial Infarction; Myocard | 1992 |
Nifedipine reduces the incidence of myocardial infarction and transient ischemia in patients undergoing coronary bypass grafting.
Topics: Coronary Artery Bypass; Coronary Disease; Humans; Myocardial Infarction; Nifedipine; Statistics as T | 1992 |
Usefulness of nifedipine in acute myocardial infarction.
Topics: Death, Sudden; Humans; Myocardial Infarction; Nifedipine; Research Design; Statistics as Topic | 1992 |
The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction.
Topics: Aged; Antigen-Antibody Complex; Aorta; Cell Migration Inhibition; Clofibric Acid; Cyclosporine; Fema | 1991 |
Acute myocardial infarction in juvenile patients with normal coronary arteries.
Topics: Adrenergic beta-Antagonists; Adult; Coronary Angiography; Humans; Myocardial Infarction; Nifedipine; | 1991 |
Sublingual nifedipine for hypertensive emergencies.
Topics: Administration, Sublingual; Cerebrovascular Disorders; Contraindications; Emergencies; Humans; Hyper | 1991 |
Effects of nifedipine on total ischemic activity in angina and the importance of in-hospital psychological stress in myocardial infarction.
Topics: Angina Pectoris; Coronary Vasospasm; Humans; Myocardial Infarction; Nifedipine; Risk Factors; Stress | 1991 |
Intraoperative myocardial ischaemia in surgical patients with treated ischaemic heart disease.
Topics: Atenolol; Blood Pressure; Coronary Disease; Electrocardiography; Female; Humans; Intraoperative Comp | 1991 |
[Use of intravenous nifedipine in the treatment of cardiac insufficiency in the acute period of myocardial infarction].
Topics: Aged; Cardiomyopathy, Dilated; Drug Administration Schedule; Female; Hemodynamics; Humans; Infusion | 1991 |
Nifedipine after coronary bypass grafting.
Topics: Coronary Artery Bypass; Humans; Myocardial Infarction; Nifedipine; Postoperative Complications | 1991 |
Risk stratification after percutaneous transluminal coronary angioplasty.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Artery Disease; Discriminant Analysi | 1990 |
[The role of therapy with a Ca++ antagonists (nifedipine) in the long-term prognosis of hypertensive patients with previous myocardial infarction].
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Hypertension; Male; Middle Aged; Myocardial Infarcti | 1990 |
Silent myocardial ischemia--classification and management.
Topics: Angina Pectoris; Atenolol; Drug Therapy, Combination; Heart Function Tests; Hemodynamics; Humans; Hy | 1990 |
Detection of silent myocardial ischemia in asymptomatic selected population and in unstable angina.
Topics: Adult; Aged; Angina, Unstable; Aspirin; Coronary Disease; Electrocardiography, Ambulatory; Exercise | 1990 |
[Effects of nifedipine on global and regional function of the left ventricle in patients with acute myocardial infarction].
Topics: Adult; Aged; Cardiac Output; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nifedipine; S | 1990 |
[Correction of metabolic disorders of the myocardium in acute myocardial infarct as an important factor in preventing the development of circulatory insufficiency].
Topics: Animals; Aprotinin; Ascorbic Acid; Drug Therapy, Combination; Glutamates; Glutamic Acid; Heart Failu | 1985 |
Nifedipine following acute myocardial infarction--dependence of response on baseline haemodynamic status.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Electrocardiography; Heart Failure; Heart Rate; Hemodyn | 1987 |
Comparative effects of nicorandil, a nicotinamide nitrate derivative, and nifedipine on myocardial reperfusion injury in dogs.
Topics: Animals; Blood Pressure; Coronary Circulation; Dogs; Female; Male; Myocardial Contraction; Myocardia | 1987 |
Effect of intravenous nifedipine on hemodynamics and left ventricular function in acute myocardial infarction.
Topics: Acute Disease; Aged; Echocardiography; Female; Heart Ventricles; Hemodynamics; Humans; Injections, I | 1987 |
[Echocardiography detection of reversible regional disorders of contraction in patients with unstable angina pectoris and Prinzmetal angina during an attack].
Topics: Angina Pectoris; Angina Pectoris, Variant; Angina, Unstable; Cardiac Catheterization; Cardiac Output | 1989 |
[The significance of a staged diagnostic-therapeutic program for the disease course in patients following unstable angina pectoris during a follow-up period of 3 1/2 years].
Topics: Angina Pectoris; Angina, Unstable; Angioplasty, Balloon; Combined Modality Therapy; Coronary Disease | 1989 |
Cardioprotective effects of amlodipine in the ischemic-reperfused heart.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cats; Dogs; Heart; In Vitro Techniques; Myocardial Co | 1989 |
Cardioprotective effects of amlodipine in the ischemic-reperfused heart.
Topics: Amlodipine; Animals; Blood Pressure; Calcium; Calcium Channel Blockers; Cats; Compliance; Coronary C | 1989 |
Impending myocardial infarction in a patient with marked left ventricular hypertrophy and normal coronary arteriogram--a case report.
Topics: Angiocardiography; Angiography; Cardiomegaly; Coronary Angiography; Echocardiography; Electrocardiog | 1989 |
Hypertensive crisis during coronary vessel surgery.
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Coronary Disease; Coronary Vessels; Humans; Hyp | 1989 |
Adverse effects of sublingual nifedipine in acute myocardial infarction.
Topics: Acute Disease; Administration, Sublingual; Humans; Myocardial Infarction; Nifedipine | 1989 |
Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs.
Topics: Animals; Bepridil; Calcium Channel Blockers; Cardiac Pacing, Artificial; Consciousness; Dogs; Electr | 1989 |
[Effects of m-nisoldipine on ischemic arrhythmia in conscious rats].
Topics: Animals; Arrhythmias, Cardiac; Blood Flow Velocity; Calcium Channel Blockers; Coronary Circulation; | 1989 |
Sequential intervention procedures after intracoronary thrombolysis; balloon dilatation, bypass surgery, and medical treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angioplasty, Balloon; Anti-Arrhythmia Agents; Combined Mod | 1985 |
[Efficacy of fenigidin, senzit and trazikor in the treatment of patients with angina pectoris].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Calcium; Cardiac Glycosides; Drug Therapy, Combi | 1985 |
Coronary and systemic hemodynamic effects of intravenous nisoldipine.
Topics: Adrenergic beta-Antagonists; Adult; Coronary Circulation; Coronary Vessels; Female; Hemodynamics; Hu | 1986 |
The use of beta-adrenergic blocking agents, i.v. nitrates and calcium channel blocking agents following acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Humans; Infusions, Intravenous; Metoprolol; M | 1988 |
Adverse effects of sublingual nifedipine in acute myocardial infarction.
Topics: Administration, Sublingual; Chest Pain; Heart Arrest; Humans; Hypotension; Male; Middle Aged; Myocar | 1989 |
Calcium-blocker withdrawal phenomenon: increase in affinity of alpha 2 adrenoceptors for agonist as a potential mechanism.
Topics: Adult; Angina Pectoris; Blood Platelets; Calcium Channel Blockers; Coronary Disease; Epinephrine; Hu | 1986 |
ECT-induced asystole from a sub-convulsive shock.
Topics: Aged; Anesthesia, Intravenous; Arrhythmias, Cardiac; Atropine; Electroconvulsive Therapy; Heart Arre | 1988 |
Comparison of different pharmacological interventions on enzymatic parameters during acute myocardial infarction.
Topics: Adult; Aged; Clinical Enzyme Tests; Creatine Kinase; Dipyridamole; Female; Heart; Heparin; Humans; I | 1987 |
Experimental coronary artery spasm-induced thrombosis and myocardial infarction prevented by intravenous nifedipine. A study of hemodynamics, electrocardiograms, biochemistry and pathology.
Topics: Animals; Coronary Disease; Coronary Thrombosis; Coronary Vasospasm; Dogs; Electrocardiography; Hemod | 1988 |
Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Dogs; Fem | 1987 |
Clinical experience of percutaneous transluminal coronary angioplasty--technique and results.
Topics: Adult; Aged; Angina Pectoris; Angioplasty, Balloon; Aspirin; Coronary Angiography; Coronary Disease; | 1985 |
[Treatment of hypertension during acute myocardial infarct and unstable angina].
Topics: Aged; Angina Pectoris; Angina, Unstable; Female; Humans; Hypertension; Male; Myocardial Infarction; | 1988 |
Nifedipine induced gingival hyperplasia.
Topics: Diabetes Mellitus, Type 2; Female; Gingival Hyperplasia; Humans; Middle Aged; Myocardial Infarction; | 1988 |
Inhibitory effect of KW-3049, a new 1,4-dihydropyridine calcium antagonist, on the reduction of myocardial creatine kinase activity and high-energy phosphate content in rats subjected to coronary artery ligation.
Topics: Adenosine Triphosphate; Animals; Calcium Channel Blockers; Coronary Circulation; Creatine Kinase; Li | 1988 |
Effects of calcium channel blocker on responses of blood flow, function, arrhythmias, and extent of infarction following reperfusion in conscious baboons.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Cre | 1988 |
Nifedipine, hypotension, and myocardial injury.
Topics: Administration, Sublingual; Aged; Female; Humans; Hypotension; Myocardial Infarction; Nifedipine | 1988 |
[Effect of corinfar and finoptin on lipid peroxidation].
Topics: Adult; Calcium Channel Blockers; Cerebrovascular Disorders; Humans; Lipid Peroxides; Middle Aged; My | 1988 |
Combined effect of propranolol and nifedipine on infarct size in dogs.
Topics: Animals; Dogs; Drug Therapy, Combination; Female; Hemodynamics; Male; Myocardial Infarction; Nifedip | 1986 |
[Use of nifedipine for treating heart failure in the subacute period of myocardial infarct in patients over 60].
Topics: Aged; Aged, 80 and over; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle | 1987 |
[Evaluation of the mechanisms of exercise induced ST elevation in old anterior myocardial infarction by cardiac blood pool scan].
Topics: Electrocardiography; Female; Heart; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infa | 1987 |
[Comparative hemodynamic effects of nifedipine, verapamil and diltiazem in cases of acute myocardial infarction].
Topics: Diltiazem; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Nifedipine; Verapamil | 1986 |
Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies.
Topics: Administration, Oral; Coronary Disease; Electrocardiography; Emergencies; Female; Humans; Hypertensi | 1987 |
Comparison of the acute hemodynamic response to intravenous nisoldipine (Bay k 5552) and intravenous nifedipine for left ventricular dysfunction secondary to myocardial infarction.
Topics: Aged; Depression, Chemical; Female; Heart Ventricles; Hemodynamics; Humans; Infusions, Intravenous; | 1987 |
Nifedipine infusion in acute myocardial infarction: experience in twelve patients.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Female; Heart Rate; Hemodynamics; Humans; Infusio | 1987 |
Effect of sublingual nifedipine on infarct size in acute myocardial infarction as determined by precordial ECG mapping.
Topics: Administration, Sublingual; Adult; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardia | 1987 |
Acute hemodynamic effects of nifedipine during supine exercise in patients with prior myocardial infarction.
Topics: Adult; Aged; Cardiac Catheterization; Cardiac Output; Exercise Test; Heart Rate; Hemodynamics; Human | 1986 |
Nifedipine--a survey of adverse effects. Four years' reporting in Sweden.
Topics: Adult; Aged; Angina Pectoris; Confusion; Erythema; Female; Headache; Heart Failure; Humans; Male; Mi | 1986 |
The long-term outcome of patients who suffered and survived an acute myocardial infarction in the midst of recurrent attacks of variant angina.
Topics: Angina Pectoris, Variant; Cardiac Catheterization; Drug Therapy, Combination; Electrocardiography; F | 1986 |
[Hand-grip test in infarct patients. Hemodynamic evaluation before and after the sublingual administration of nifedipine].
Topics: Administration, Oral; Blood Pressure; Heart Rate; Humans; Isometric Contraction; Male; Middle Aged; | 1986 |
Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs.
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Dogs; Female; Hemodynamics; M | 1986 |
[Effect of nifedipine in chronic left ventricular insufficiency in patients with post-infarction heart aneurysm].
Topics: Adult; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Chronic Disease; Heart Aneurysm; Hem | 1986 |
Silent myocardial ischemia: clinical characteristics, underlying mechanisms, and implications for treatment.
Topics: Angina, Unstable; Coronary Circulation; Coronary Disease; Electrocardiography; Exercise Test; Follow | 1986 |
Acute myocardial infarction in a patient with anomalous right coronary artery.
Topics: Aged; Coronary Circulation; Coronary Vessel Anomalies; Female; Humans; Myocardial Infarction; Nifedi | 1986 |
Calcium antagonists and evolving myocardial infarction: studies of the effects of nifedipine on tissue ATP, collateral flow and infarct size in the closed chest dog.
Topics: Adenosine Triphosphate; Animals; Collateral Circulation; Coronary Circulation; Dogs; Electrocardiogr | 1986 |
[Hemodynamic effects of nifedipine in acute myocardial infarction].
Topics: Adult; Aged; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nifedipine | 1985 |
Is anesthesia beneficial for the ischemic heart? III.
Topics: Adult; Age Factors; Aged; Anesthesia; Coronary Circulation; Coronary Disease; Hemodynamics; Humans; | 1986 |
Aggravation of myocardial ischaemia by nifedipine.
Topics: Coronary Disease; Female; Humans; Hypotension; Male; Middle Aged; Myocardial Infarction; Nifedipine; | 1985 |
Potential prevention of myocardial rupture resulting from acute myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Female; Heart Rupture; Heart Septum; Heart Ventricles; Humans; Hyperte | 1985 |
Verapamil and nifedipine limit infarct size in the dog.
Topics: Animals; Coronary Circulation; Dogs; Female; Hemodynamics; Male; Myocardial Infarction; Myocardium; | 1985 |
[Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
Topics: Cardiomyopathy, Dilated; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Hydralazine | 1985 |
[Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction].
Topics: Aged; Calcium Channel Blockers; Diltiazem; Drug Evaluation; Echocardiography; Female; Hemodynamics; | 1985 |
Effect of verapamil, nifedipine and diltiazem on experimental myocardial infarction in rats.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Female; Isoproterenol; Male; Myocardial Infarction; Ni | 1985 |
Nicardipine in models of myocardial infarction.
Topics: Animals; Calcium Channel Blockers; Disease Models, Animal; Dogs; Electrocardiography; Heart Conducti | 1985 |
[Effects of sublingual nifedipine on hemodynamic responses to exercise in patients with myocardial infarction].
Topics: Adult; Aged; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nifedipine; Physical Ex | 1985 |
[Comparative study of the activity of fendiline and nifedipine in ischemic heart disease].
Topics: Adult; Aged; Angina Pectoris; Coronary Disease; Electrocardiography; Female; Fendiline; Humans; Male | 1985 |
The effect of the new calcium antagonist nisoldipine (BAY k-5552) on myocardial infarct size limitation in conscious dogs.
Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Calcium Channel Blockers; Dogs; Female; Heart | 1985 |
Quinidine-nifedipine interaction.
Topics: Aged; Biological Availability; Drug Interactions; Humans; Lidocaine; Male; Myocardial Infarction; Ni | 1985 |
[Induced platelet aggregation in patients with coronary heart disease as well as trained and untrained control persons].
Topics: Adult; Cholesterol; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction; Nifedipine; | 1985 |
The actions of felodipine on arrhythmias and other responses to myocardial ischaemia in conscious rats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Electrocard | 1985 |
Acute effects of sublingual nifedipine on segmental and global left ventricular function in coronary artery disease; an angiographic study.
Topics: Administration, Oral; Adult; Aged; Cardiac Output; Coronary Disease; Electrocardiography; Heart Vent | 1985 |